Disease Progression

• 

  Subject Areas on Research

  • "ALS reversals": demographics, disease characteristics, treatments, and co-morbidities. 
  • "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma. 
  • "Still" ill? 
  • "What concerns me is..." Expression of emotion by advanced cancer patients during outpatient visits. 
  • 'Smooth' inference for survival functions with arbitrarily censored data. 
  • (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. 
  • (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. 
  • 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry. 
  • 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice. 
  • 9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901. 
  • A "best-in-class" systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression. 
  • A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. 
  • A 3D Poly(ethylene glycol)-based Tumor Angiogenesis Model to Study the Influence of Vascular Cells on Lung Tumor Cell Behavior. 
  • A 5-year followup study of asymptomatic men with testicular microlithiasis. 
  • A Bayesian approach to joint analysis of multivariate longitudinal data and parametric accelerated failure time. 
  • A Case of Progressive Dimming Vision. 
  • A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis. 
  • A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF). 
  • A Novel Method to Estimate Long-Term Chronological Changes From Fragmented Observations in Disease Progression. 
  • A Novel Murine Model of Marfan Syndrome Accelerates Aortopathy and Cardiomyopathy. 
  • A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. 
  • A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2). 
  • A SAGE (serial analysis of gene expression) view of breast tumor progression. 
  • A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice. 
  • A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. 
  • A computer-aided diagnosis system of nuclear cataract. 
  • A flexible parametric model for combining current status and age at first diagnosis data. 
  • A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. 
  • A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer. 
  • A hypertension risk score for middle-aged and older adults. 
  • A longitudinal study of neurocognitive function in individuals at-risk for psychosis. 
  • A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis. 
  • A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma. 
  • A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. 
  • A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer. 
  • A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma. 
  • A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial. 
  • A natural history of melanoma: serial gene expression analysis. 
  • A new locus for familial FSGS on chromosome 2p. 
  • A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor. 
  • A nonlinear quasi-static model of intracranial aneurysms. 
  • A novel bioreactor for combined magnetic resonance spectroscopy and optical imaging of metabolism in 3D cell cultures. 
  • A novel human disease with abnormal prion protein sensitive to protease. 
  • A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors. 
  • A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma. 
  • A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours. 
  • A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel. 
  • A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042). 
  • A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer. 
  • A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. 
  • A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study. 
  • A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial. 
  • A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides. 
  • A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and Leukemia Group B 99813. 
  • A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium. 
  • A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients. 
  • A phase II trial of temsirolimus in men with castration-resistant metastatic prostate cancer. 
  • A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. 
  • A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. 
  • A population-based study of the association between coronary artery bypass graft surgery (CABG) and cognitive decline: the Cache County study. 
  • A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate. 
  • A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data. 
  • A prospective study of outcomes of nursing home residents with chronic kidney disease with and without anemia. 
  • A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer. 
  • A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team. 
  • A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia. 
  • A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers. 
  • A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination. 
  • A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. 
  • A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events. 
  • A randomized trial of diet in men with early stage prostate cancer on active surveillance: rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]). 
  • A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team. 
  • A retrospective review of the management of Dupuytren's nodules. 
  • A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. 
  • A role for peroxisome proliferator-activated receptor γ coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth. 
  • A role of matrix metalloproteinase-8 in atherosclerosis. 
  • A semiparametric likelihood approach to joint modeling of longitudinal and time-to-event data. 
  • A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity. 
  • A single-arm phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology with disease progression on bevacizumab containing therapy. 
  • A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. 
  • A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. 
  • A whole-genome association study of major determinants for host control of HIV-1. 
  • ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. 
  • ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. 
  • AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganization. 
  • AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma. 
  • ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase". 
  • ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics. 
  • ALSUntangled 41: "Eric Is Winning". 
  • ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. 
  • APOE genotype regulates pathology and disease progression in synucleinopathy. 
  • APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. 
  • ATM deficiency promotes progression of CRPC by enhancing Warburg effect. 
  • Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial. 
  • Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. 
  • Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children. 
  • Accelerated Marfan syndrome model recapitulates established signaling pathways. 
  • Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. 
  • Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. 
  • Accuracy of detecting enlargement of aneurysms using different MRI modalities and measurement protocols. 
  • Actigraphic-measured sleep disturbance predicts increased positive symptoms in adolescents at ultra high-risk for psychosis: A longitudinal study. 
  • Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer. 
  • Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. 
  • Active surveillance for early-stage prostate cancer: review of the current literature. 
  • Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer. 
  • Acute HIV-1 Infection. 
  • Acute Presentation of Previously Unrecognized Congenital Ureteropelvic Junction Obstruction 5 Weeks After Radical Retropubic Prostatectomy. 
  • Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression. 
  • Acute kidney injury to chronic kidney disease transition: insufficient cellular stress response. 
  • Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model. 
  • Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Adherence to quality indicators and survival in patients with breast cancer. 
  • Admission to the intensive care unit and well-being in patients with advanced chronic illness. 
  • Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up. 
  • Adult Functional Outcomes of Common Childhood Psychiatric Problems: A Prospective, Longitudinal Study. 
  • Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. 
  • Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: a database analysis. 
  • Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. 
  • Advanced heart failure. 
  • Advanced heart failure: a call to action. 
  • Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. 
  • Adverse events after intravitreal triamcinolone in patients with and without uveitis. 
  • Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: is adjuvant radiation warranted? 
  • African American Men With Low-Risk Prostate Cancer Are Candidates for Active Surveillance: The Will-Rogers Effect? 
  • After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. 
  • Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. 
  • Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network. 
  • Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children. 
  • Age-related macular degeneration and progression of coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis. 
  • Age-related macular degeneration. 
  • Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials. 
  • Algorithms for optimizing the treatment of depression: making the right decision at the right time. 
  • Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis. 
  • Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis. 
  • Alpha C-telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis. 
  • Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. 
  • Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 
  • Alternative splicing in Acad8 resulting a mitochondrial defect and progressive hepatic steatosis in mice. 
  • Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer. 
  • American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. 
  • American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. 
  • American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. 
  • Amnestic mild cognitive impairment and incident dementia and Alzheimer's disease in geriatric depression. 
  • Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. 
  • Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site. 
  • Amyloid beta-positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity. 
  • An Asthma Protocol Improved Adherence to Evidence-Based Guidelines for Pediatric Subjects With Status Asthmaticus in the Emergency Department. 
  • An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer. 
  • An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme. 
  • An evidence-based update on myopia and interventions to retard its progression. 
  • An infant with subvalvar and valvar aortic stenosis, subvalvar and valvar pulmonary stenosis, severe biventricular hypertrophy and pulmonary hemorrhage. 
  • An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. 
  • An outcome model approach to transporting a randomized controlled trial results to a target population. 
  • Anaemia and coronary artery disease severity in patients with heart failure. 
  • Analysis of Peripapillary Atrophy in Relation to Macular Geographic Atrophy in Age-Related Macular Degeneration. 
  • Analysis of current multiple sclerosis registries. 
  • Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry. 
  • Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. 
  • Analysis of post-transcriptional regulation during cancer progression using a donor-derived isogenic model of tumorigenesis. 
  • Analysis of prognosis and disease progression after local recurrence of melanoma. 
  • Androgen deprivation therapy for the treatment of prostate cancer: a focus on pharmacokinetics 
  • Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer. 
  • Androgen-independent prostate cancer progression in the TRAMP model. 
  • Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function. 
  • Aneurysms in abdominal organ transplant recipients. 
  • Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy. 
  • Angiographic changes in vein grafts: stable surrogate or seductive siren? 
  • Angiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progression. 
  • Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. 
  • Animal models in the research of abdominal aortic aneurysms development. 
  • Animal models of heart failure: a scientific statement from the American Heart Association. 
  • Animal models of human prostate cancer: the consensus report of the New York meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee. 
  • Animal models of steatohepatitis. 
  • Anterior rectal wall gastrointestinal stromal tumor presenting clinically as prostatic mass. 
  • Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome. 
  • Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. 
  • Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. 
  • Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 
  • Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review. 
  • Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. 
  • Anti-epidermal growth factor receptor therapy for glioblastoma in adults. 
  • Anti-tumor immunity: myeloid leukocytes control the immune landscape. 
  • Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial. 
  • Anticoagulant therapy in unstable angina. 
  • Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. 
  • Antifibrotic Therapy: Is There a Role in Myositis-Interstitial Lung Disease? 
  • Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development. 
  • Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease. 
  • Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7. 
  • Anxiety sensitivity as a predictor of the clinical course of panic disorder: a 1-year follow-up study. 
  • Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. 
  • Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. 
  • Aortic root diameter and longitudinal blood pressure tracking. 
  • ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. 
  • Apolipoprotein E and neuromuscular disease: a critical review of the literature. 
  • Application of Traditional and Emerging Methods for the Joint Analysis of Repeated Measurements With Time-to-Event Outcomes in Rheumatology. 
  • Application of a new multinomial phase II stopping rule using response and early progression. 
  • Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia. 
  • Application of longitudinal item response theory models to modeling Parkinson's disease progression. 
  • Application of neuropsychological criteria to classify mild cognitive impairment in the active study. 
  • Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. 
  • Applying the neoadjuvant paradigm to ductal carcinoma in situ. 
  • Are antioxidants or other supplements protective for age-related macular degeneration? 
  • Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease. 
  • Arrhythmias in patients with hypoplastic left heart syndrome. 
  • Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices. 
  • Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF). 
  • Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques. 
  • Assessing neurocognitive dysfunction in cranial radiotherapy: can cognitive event-related potentials help? 
  • Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial. 
  • Assessing the impact of a remote digital coaching engagement program on patient-reported outcomes in asthma. 
  • Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. 
  • Assessment of hand osteoarthritis: correlation between thermographic and radiographic methods. 
  • Assessment of image-derived risk factors for natural course of unruptured cerebral aneurysms. 
  • Assessment of liver fibrosis progression and regression by a serological collagen turnover profile. 
  • Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC). 
  • Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. 
  • Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. 
  • Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. 
  • Association Between Long-Term Blood Pressure Variability and 10-Year Progression in Arterial Stiffness: The Multiethnic Study of Atherosclerosis. 
  • Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease. 
  • Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel. 
  • Association Between Serum Vitamin D Level and Rates of Structural and Functional Glaucomatous Progression. 
  • Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life. 
  • Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. 
  • Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. 
  • Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. 
  • Association between serum and urine biomarkers and lumbar spine individual radiographic features: the Johnston County Osteoarthritis Project. 
  • Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. 
  • Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney Disease. 
  • Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. 
  • Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression. 
  • Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease. 
  • Association of IL6ST (gp130) Polymorphism with Functional Outcome Following Spontaneous Intracerebral Hemorrhage. 
  • Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease. 
  • Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance. 
  • Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. 
  • Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population. 
  • Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA. 
  • Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial. 
  • Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. 
  • Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. 
  • Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry. 
  • Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. 
  • Associations between the chemokine biomarker CCL2 and knee osteoarthritis outcomes: the Johnston County Osteoarthritis Project. 
  • Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure. 
  • Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. 
  • Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. 
  • Atherosclerosis and cancer: common molecular pathways of disease development and progression. 
  • Atrial Fibrillation and Risk of ESRD in Adults with CKD. 
  • Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices. 
  • Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome. 
  • Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. 
  • Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. 
  • Attrition of memory CD8 T cells during sepsis requires LFA-1. 
  • Atypical Rapidly Enlarging Orbital Schwannoma. 
  • Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls. 
  • Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab. 
  • Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression. 
  • Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. 
  • Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial. 
  • Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience. 
  • Automated detection of physiologic deterioration in hospitalized patients. 
  • Autophagy links inflammasomes to atherosclerotic progression. 
  • Avascular necrosis of the femoral head: etiology, pathophysiology, classification, and current treatment guidelines. 
  • B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. 
  • B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation. 
  • B6 and Bleeding: A Case Report of a Novel Vitamin Toxicity. 
  • BASELINE CHARACTERISTICS OF VITREOMACULAR TRACTION PROGRESSING TO FULL-THICKNESS MACULAR OR LAMELLAR HOLES IN THE PHASE III TRIALS OF ENZYMATIC VITREOLYSIS. 
  • BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide. 
  • BCR-NTRK2 fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behavior. 
  • BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression. 
  • BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis. 
  • Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults. 
  • Barrett's esophagus in 2008: an update. 
  • Baseline Prostate Atrophy is Associated with Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy. 
  • Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity. 
  • Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). 
  • Bayesian inference and dynamic prediction of multivariate joint model with functional data: An application to Alzheimer's disease. 
  • Bayesian modeling of incidence and progression of disease from cross-sectional data. 
  • Bayesian quantile regression joint models: Inference and dynamic predictions. 
  • Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. 
  • Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses. 
  • Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. 
  • Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients. 
  • Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study. 
  • Bevacizumab for the treatment of high-grade glioma. 
  • Bevacizumab in colorectal cancer. 
  • Bi-allelic KARS1 pathogenic variants affecting functions of cytosolic and mitochondrial isoforms are associated with a progressive and multisystem disease. 
  • Bidimensional measurements in brain tumors: assessment of interobserver variability. 
  • Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts. 
  • Biochemical recurrence after definitive prostate cancer therapy. Part I: defining and localizing biochemical recurrence of prostate cancer. 
  • Biochemical recurrence after definitive prostate cancer therapy. Part II: treatment strategies for biochemical recurrence of prostate cancer. 
  • Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer. 
  • Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. 
  • Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progression. 
  • Biomarkers as surrogate end points in heart failure trials. 
  • Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy. 
  • Biomarkers in cardiovascular clinical trials: past, present, future. 
  • Biomarkers in rheumatologic disease: a review. 
  • Biomarkers of inflammation - LBP and TLR- predict progression of knee osteoarthritis in the DOXY clinical trial. 
  • Biomarkers predict progression of acute kidney injury after cardiac surgery. 
  • Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease. 
  • Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. 
  • Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches. 
  • Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review. 
  • Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes. 
  • Blood Lead, Bone Turnover, and Survival in Amyotrophic Lateral Sclerosis. 
  • Blood Pressure and Glaucomatous Progression in a Large Clinical Population. 
  • Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. 
  • Blood gene expression signatures predict invasive candidiasis. 
  • Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis. 
  • Bosniak category IIF and III cystic renal lesions: outcomes and associations. 
  • Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. 
  • Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators. 
  • Brain-stem auditory and visual evoked potentials in children with Krabbe disease. 
  • Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease. 
  • Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma. 
  • Brief Report: Cartilage Thickness Change as an Imaging Biomarker of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. 
  • Bronchodilators in heart failure patients with COPD: is it time for a clinical trial? 
  • Burden of pancreatic cancer and disease progression: economic analysis in the US. 
  • C-reactive protein as a marker of melanoma progression. 
  • CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. 
  • CAP--advancing the evaluation of preclinical Alzheimer disease treatments. 
  • CCL3L1 and HIV/AIDS susceptibility. 
  • CCR5del32 in perinatal HIV-1 infection. 
  • CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. 
  • CD8+ cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines. 
  • CKD progression and mortality among older patients with diabetes. 
  • COVID-19-accelerated disease progression in two patients with amyotrophic lateral sclerosis. 
  • CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression. 
  • CSF biomarker changes precede symptom onset of mild cognitive impairment. 
  • CT abdominal imaging findings in patients with sickle cell disease: acute vaso-occlusive crisis, complications, and chronic sequelae. 
  • CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways. 
  • CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels. 
  • Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. 
  • Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. 
  • Cancer Outcomes in DCIS Patients Without Locoregional Treatment. 
  • Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer. 
  • Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma. 
  • Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX. 
  • Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study. 
  • Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. 
  • Cardiac troponins in congestive heart failure. 
  • Cardiorenal interactions: insights from the ESCAPE trial. 
  • Cardiorenal syndrome clinical trial end points. 
  • Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. 
  • Cardioversion and subsequent quality of life and natural history of atrial fibrillation. 
  • Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. 
  • Caregiver-Reported Sleep Disturbances Are Associated With Behavioral and Psychological Symptoms in an Asian Elderly Cohort With Cognitive Impairment-No Dementia. 
  • Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. 
  • Caring for patients with chronic heart failure: The trajectory model. 
  • Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. 
  • Cataract formation in a strain of rats selected for high oxidative stress. 
  • Catechol-O-methyltransferase genotype predicts pain severity in hospitalized burn patients. 
  • Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. 
  • Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers. 
  • Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis. 
  • Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial. 
  • Cementation for femoral head osteonecrosis: a preliminary clinic study. 
  • Central corneal thickness in children--does it help or hinder our evaluation of eyes at risk for glaucoma? 
  • Cerebral phaeohyphomycosis mimics high-grade astrocytoma. 
  • Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. 
  • Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. 
  • Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre-Specified Analysis of Two Phase III Trials. 
  • Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX. 
  • Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial. 
  • Challenges in the diagnosis and treatment of juvenile systemic sclerosis. 
  • Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study. 
  • Change in peripheral refraction over time in Singapore Chinese children. 
  • Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon-Schuss radiography. 
  • Changes in brain function occur years before the onset of cognitive impairment. 
  • Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative. 
  • Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. 
  • Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. 
  • Changes in oligosaccharide chains of autoantibodies to GRP78 expressed during progression of malignant melanoma stimulate melanoma cell growth and survival. 
  • Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. 
  • Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. 
  • Changes in retinal venular oxygen saturation predict activity of proliferative diabetic retinopathy 3 months after panretinal photocoagulation. 
  • Changing pattern of organ dysfunction in early human sepsis is related to mortality. 
  • Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease. 
  • Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades-2000-2020. 
  • Characteristics and Trends Among Patients With Cardiovascular Disease Referred to Palliative Care. 
  • Characteristics and outcomes of patients with heart failure and discordant findings by right-sided heart catheterization and cardiopulmonary exercise testing. 
  • Characteristics of Framingham offspring participants with long-lived parents. 
  • Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy. 
  • Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope. 
  • Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. 
  • Characterization of gait in late onset Pompe disease. 
  • Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. 
  • Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set. 
  • Characterizing the impact of 25 years of DCIS treatment. 
  • Characterizing the phenotype of advanced pelvic organ prolapse. 
  • Chemopotentiation by ultrafractionated radiotherapy in glioblastoma resistant to conventional therapy. 
  • Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance). 
  • Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection. 
  • Chemotherapy for advanced prostate cancer: results of new clinical trials and future studies. 
  • Childhood Factors Affecting Persistence and Desistence of Attention-Deficit/Hyperactivity Disorder Symptoms in Adulthood: Results From the MTA. 
  • Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity. 
  • Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. 
  • Chondrocyte-Specific RUNX2 Overexpression Accelerates Post-traumatic Osteoarthritis Progression in Adult Mice. 
  • Chromosomal comparative genomic hybridization abnormalities in early- and late-onset human breast cancers: correlation with disease progression and TP53 mutations. 
  • Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Chronic abdominal pain in a liver transplant recipient. 
  • Chronic hepatitis C: an age wave of disease burden. 
  • Chronic myelogenous leukemia. 
  • Chronic myelogenous leukemia. 
  • Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. 
  • Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. 
  • Chronic widespread pain after motor vehicle collision typically occurs through immediate development and nonrecovery: results of an emergency department-based cohort study. 
  • Chronic wound repair and healing in older adults: current status and future research. 
  • Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD. 
  • Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium. 
  • Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial. 
  • CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis. 
  • Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. 
  • Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis. 
  • Circulating biomarkers for abdominal aortic aneurysm: what did we learn in the last decade? 
  • Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. 
  • Circulating tumor cell analysis in metastatic triple-negative breast cancers. 
  • Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. 
  • Classification of osteoarthritis biomarkers: a proposed approach. 
  • Clenbuterol Treatment Is Safe and Associated With Slowed Disease Progression in a Small Open-Label Trial in Patients With Amyotrophic Lateral Sclerosis. 
  • Clin-Star corner: What is new at the interface of geriatrics and nephrology? 
  • Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database. 
  • Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry. 
  • Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. 
  • Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration. 
  • Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial. 
  • Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. 
  • Clinical and electroencephalographic correlates in Rasmussen's encephalitis. 
  • Clinical and histologic findings in patients with uveal melanomas after taking tumor necrosis factor-α inhibitors. 
  • Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. AIDS Clinical Trials Group Protocol 152 Study Team. 
  • Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease. 
  • Clinical aspects of monoclonal B-cell lymphocytosis. 
  • Clinical characteristics and outcomes in biclonal gammopathies. 
  • Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade. 
  • Clinical endpoints for drug development in prostate cancer. 
  • Clinical events and patient-reported outcome measures during CKD progression: findings from the Chronic Renal Insufficiency Cohort Study. 
  • Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. 
  • Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure. 
  • Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience. 
  • Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies. 
  • Clinical phenotypes associated with circulating tumor cell enumeration in metastatic castration-resistant prostate cancer. 
  • Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. 
  • Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial. 
  • Clinical reactivations of herpes simplex virus type 2 infection and human immunodeficiency virus disease progression markers. 
  • Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. 
  • Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. 
  • Clinical trial evidence for treatment of depression in heart failure. 
  • Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease. 
  • Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and compliance. 
  • Clinical validation of a customized multiple signature microarray for breast cancer. 
  • Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. 
  • Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis. 
  • Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. 
  • Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression. 
  • Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. 
  • Clonal expansion and decreased occurrence of peripheral blood gamma delta T cells of the V delta 2J delta 3 lineage in multiple sclerosis patients. 
  • Clonal haematopoiesis and risk of chronic liver disease. 
  • Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. 
  • Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study. 
  • Cognitive training and neuroplasticity in mild cognitive impairment (COG-IT): protocol for a two-site, blinded, randomised, controlled treatment trial. 
  • Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. 
  • Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. 
  • Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial. 
  • Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. 
  • Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. 
  • Colon cancer, version 3.2014. 
  • Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments. 
  • Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. 
  • Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. 
  • Combined lung-liver-pancreas transplantation in a recipient with cystic fibrosis. 
  • Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. 
  • Common genetic variation and the control of HIV-1 in humans. 
  • Communication around palliative care principles and advance care planning between oncologists, children with advancing cancer and families. 
  • Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. 
  • Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly Patients. 
  • Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. 
  • Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. 
  • Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. 
  • Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. 
  • Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial. 
  • Comparing rates of retinal nerve fibre layer loss with GDxECC using different methods of visual-field progression. 
  • Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT. 
  • Comparison of Cartilage Mechanical Properties Measured During Creep and Recovery. 
  • Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights From the PROMISE and SCOT-HEART. 
  • Comparison of Short- And Long-Term Variability in Standard Perimetry and Spectral Domain Optical Coherence Tomography in Glaucoma. 
  • Comparison of Visual Outcomes in Coats' Disease: A 20-Year Experience. 
  • Comparison of animal models for head and neck cancer cachexia. 
  • Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease. 
  • Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis. 
  • Comparison of results of percutaneous balloon mitral commissurotomy in patients aged > or = 65 years with those in patients aged < 65 years. 
  • Competing Risk of Death With End-Stage Renal Disease in Diabetic Kidney Disease. 
  • Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease. 
  • Competing Risks of Mortality among Men with Biochemical Recurrence after Radical Prostatectomy. 
  • Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia. 
  • Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment. 
  • Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease. 
  • Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma. 
  • Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis. 
  • Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual. 
  • Consciousness, coma, and caring for the brain-injured patient. 
  • Consortium to establish a registry for Alzheimer's disease: development, database structure, and selected findings. 
  • Contemporary approach to the diagnosis and management of non-ST-segment elevation acute coronary syndromes. 
  • Continuity and stability of preschool depression from childhood through adolescence and following the onset of puberty. 
  • Continuous DC-CIK infusions restore CD8+ cellular immunity, physical activity and improve clinical efficacy in advanced cancer patients unresponsive to conventional treatments. 
  • Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer. 
  • Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates. 
  • Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. 
  • Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. 
  • Conversion to dementia from mild cognitive disorder: the Cache County Study. 
  • Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure. 
  • Corneal Hysteresis for the Diagnosis of Glaucoma and Assessment of Progression Risk: A Report by the American Academy of Ophthalmology. 
  • Correlates of care relationship mutuality among carers of people with Alzheimer's and Parkinson's disease. 
  • Correlates of protective viruses damaging to HIV infection. 
  • Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques. 
  • Correlation between pericardial, mediastinal, and intrathoracic fat volumes with the presence and severity of coronary artery disease, metabolic syndrome, and cardiac risk factors. 
  • Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. 
  • Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? 
  • Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. 
  • Cost-effectiveness of HIV screening in patients older than 55 years of age. 
  • Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. 
  • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. 
  • Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease. 
  • Creatine for amyotrophic lateral sclerosis/motor neuron disease. 
  • Creatine for amyotrophic lateral sclerosis/motor neuron disease. 
  • Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS. 
  • Critical review: is watchful waiting a viable management option for older men with prostate cancer? 
  • Critical role of TNF-α in cerebral aneurysm formation and progression to rupture. 
  • Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes. 
  • Cryptococcus neoformans hyperfilamentous strain is hypervirulent in a murine model of cryptococcal meningoencephalitis. 
  • Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant. 
  • CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. 
  • Current management of aortic arch lesions with hybrid procedures: a tailored approach to a progressive disease. 
  • Current management of glaucoma and the need for complete therapy. 
  • Current status of fibrosis markers. 
  • Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy. 
  • Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications. 
  • Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. 
  • Cyclic coronary flow: defining preinfarction angina at the crossroads of unstable angina and myocardial infarction. 
  • Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis. 
  • Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2. 
  • Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections. 
  • Cytokines in alcoholic and nonalcoholic steatohepatitis. 
  • DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations. 
  • DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma. 
  • DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions. 
  • Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. 
  • Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. 
  • Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry. 
  • Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. 
  • Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model. 
  • Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. 
  • Deep recurrent model for individualized prediction of Alzheimer's disease progression. 
  • Deep venous thrombosis: withholding anticoagulation therapy after negative complete lower limb US findings. 
  • Default mode network connectivity in stable vs progressive mild cognitive impairment. 
  • Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score. 
  • Defining meaningful change in Alzheimer's disease trials: the donepezil experience. 
  • Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer. 
  • Delay in retinal photoreceptor development in very preterm compared to term infants. 
  • Delayed Admissions to the Pediatric Intensive Care Unit: Progression of Disease or Errors in Emergency Department Management. 
  • Delayed Diagnosis of Disseminated Cryptococcosis with Associated Meningoencephalitis in an Immunocompetent Septuagenarian Host. 
  • Delayed endovascular revascularization in a patient with progressive neurological deterioration from bilateral intracranial vertebral artery occlusions: case report. 
  • Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. 
  • Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial. 
  • Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. 
  • Depressed older patients with the atypical features of interpersonal rejection sensitivity and reversed-vegetative symptoms are similar to younger atypical patients. 
  • Descending Aortic Distensibility and Cardiovascular Outcomes: A Cardiac Magnetic Resonance Imaging Study. 
  • Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial. 
  • Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer. 
  • Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. 
  • Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. 
  • Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial. 
  • Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma. 
  • Desmoplastic small round cell tumor masquerading as advanced ovarian cancer. 
  • Detecting glaucomatous progression using GDx with variable and enhanced corneal compensation using Guided Progression Analysis. 
  • Detection of Progressive Glaucomatous Optic Nerve Damage on Fundus Photographs with Deep Learning. 
  • Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancer. 
  • Detection of progressive retinal nerve fiber layer thickness loss with optical coherence tomography using 4 criteria for functional progression. 
  • Determinants of attrition in a natural history study of Alzheimer disease. 
  • Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer. 
  • Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE). 
  • Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells. 
  • Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa. 
  • Development of personality disorder symptoms and the risk for partner violence. 
  • Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation. 
  • Development of temporomandibular disorders is associated with greater bodily pain experience. 
  • Developmental Morphogens & Recovery from Alcoholic Liver Disease. 
  • Developmental pathways in oppositional defiant disorder and conduct disorder. 
  • Developmental transitions to psychopathology: are there prodromes of substance use disorders? 
  • Diabetes Prevention Program Translation in the Veterans Health Administration. 
  • Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy. 
  • Diabetic nephropathy: of mice and men. 
  • Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography. 
  • Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. 
  • Diagnostic and treatment challenges of neuronopathic Gaucher disease: two cases with an intermediate phenotype. 
  • Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation. 
  • Diarrhea in a Patient With Combined Kidney-Pancreas Transplant. 
  • Dichotomous roles of TGF-β in human cancer. 
  • Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. 
  • Dietary Salt Exacerbates Experimental Colitis. 
  • Dietary acid load: a novel nutritional target in chronic kidney disease? 
  • Differences in clinical features and in-hospital outcomes of older adults with tako-tsubo cardiomyopathy. 
  • Differences in health care use and outcomes by the timing of in-hospital worsening heart failure. 
  • Differential Expression of KRAS and SIRT1 in Ovarian Cancers with and Without Endometriosis. 
  • Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast. 
  • Differential myocardial gene expression in the development and rescue of murine heart failure. 
  • Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression. 
  • Differential platelet levels affect response to taxane-based therapy in ovarian cancer. 
  • Direct carotid-cavernous fistula presenting with minimal symptoms and rapid angiographic progression. 
  • Discovery of biomarker candidates for coronary artery disease from an APOE-knock out mouse model using iTRAQ-based multiplex quantitative proteomics. 
  • Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study. 
  • Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients. 
  • Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials. 
  • Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. 
  • Disease progression in iridocorneal angle tissues of BMP2-induced ocular hypertensive mice with optical coherence tomography. 
  • Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling. 
  • Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees. 
  • Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. 
  • Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT. 
  • Diuretic management in heart failure. 
  • Diuretic response in acute heart failure-an analysis from ASCEND-HF. 
  • Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses. 
  • Do biochemical markers have a role in osteoarthritis diagnosis and treatment? 
  • Do modern techniques improve core decompression outcomes for hip osteonecrosis? 
  • Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial. 
  • Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression? 
  • Does access to health care impact survival time after diagnosis of AIDS? 
  • Does ghrelin explain accelerated gastric emptying in the early stages of diabetes mellitus? 
  • Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy? 
  • Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report. 
  • Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate. 
  • Double agents in the war on cancer: leukocytes govern ovarian cancer progression. 
  • Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies. 
  • Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China. 
  • Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration. 
  • Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye. 
  • Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. 
  • Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II. 
  • Durable mechanical circulatory support devices. 
  • Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. 
  • Dynamic Responses in Retinal Vessel Caliber With Flicker Light Stimulation and Risk of Diabetic Retinopathy and Its Progression. 
  • Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. 
  • Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data. 
  • Dynamic prediction of metastases after radical prostatectomy for prostate cancer. 
  • Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer's disease. 
  • Dynamic systems theory as a paradigm for the study of change in psychotherapy: an application to cognitive therapy for depression. 
  • Dyspnea review for the palliative care professional: assessment, burdens, and etiologies. 
  • Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study. 
  • Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma. 
  • Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. 
  • Dysregulation of STAT3 signaling is associated with endplate-oriented herniations of the intervertebral disc in Adgrg6 mutant mice. 
  • EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor. 
  • Early Chemoprophylaxis Against Venous Thromboembolism in Patients With Traumatic Brain Injury. 
  • Early Endometriosis in Females Is Directed by Immune-Mediated Estrogen Receptor α and IL-6 Cross-Talk. 
  • Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*. 
  • Early aggressive treatment of lichen sclerosus may prevent disease progression. 
  • Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164. 
  • Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm: a pilot study. 
  • Early changes of lung function and structure in an elastase model of emphysema—a hyperpolarized³ He MRI study 
  • Early forming label-retaining muscle stem cells require p27kip1 for maintenance of the primitive state. 
  • Early management of atrial fibrillation to prevent cardiovascular complications. 
  • Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. 
  • Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. 
  • Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis? 
  • Early-Life Intranasal Colonization with Nontypeable Haemophilus influenzae Exacerbates Juvenile Airway Disease in Mice. 
  • Echocardiographic Indicators Associated with Adverse Clinical Course and Cardiac Sequelae in Multisystem Inflammatory Syndrome in Children with Coronavirus Disease 2019. 
  • Echocardiographic findings in fulminant and acute myocarditis. 
  • Echocardiographic quantification of left ventricular mass: prognostic implications. 
  • Echocardiography-derived tricuspid regurgitant jet velocity is an important marker for the progression of sickle-cell disease. 
  • Economic effects of beta-blocker therapy in patients with heart failure. 
  • Economics of treating heart failure. 
  • Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion. 
  • Editorial Comment on: "Ten-Year Experience with Percutaneous Cryoablation of Renal Tumors: Tumor Size Predicts Disease Progression" by Pickersgill et al. 
  • Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease. 
  • Effect of Diabetes Control on Rates of Structural and Functional Loss in Patients with Glaucoma. 
  • Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. 
  • Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. 
  • Effect of Fresh vs Standard-issue Red Blood Cell Transfusions on Multiple Organ Dysfunction Syndrome in Critically Ill Pediatric Patients: A Randomized Clinical Trial. 
  • Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. 
  • Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial. 
  • Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. 
  • Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. 
  • Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease. 
  • Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. 
  • Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. 
  • Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. 
  • Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse. 
  • Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. 
  • Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. 
  • Effect of hypercholesterolemia on transendothelial EBD-albumin permeability and lipid accumulation in porcine iliac arteries. 
  • Effect of isocaloric low fat diet on prostate cancer xenograft progression in a hormone deprivation model. 
  • Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. 
  • Effect of smoking on the clinical progression of HIV-1 infection. 
  • Effect of the isoflavone genistein against galactose-induced cataracts in rats. 
  • Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. 
  • Effects and potential mechanisms of exercise training on cancer progression: a translational perspective. 
  • Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression. 
  • Effects of Physical Activity in Knee and Hip Osteoarthritis: A Systematic Umbrella Review. 
  • Effects of Serelaxin in Patients with Acute Heart Failure. 
  • Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS). 
  • Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study. 
  • Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression. 
  • Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance. 
  • Efficacy and Mechanisms of Aerobic Exercise on Cancer Initiation, Progression, and Metastasis: A Critical Systematic Review of In Vivo Preclinical Data. 
  • Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial. 
  • Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. 
  • Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study. 
  • Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. 
  • Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
  • Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution. 
  • Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. 
  • Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events. 
  • Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men. 
  • Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif. 
  • Emerging Therapies for Congestive Heart Failure. 
  • Empagliflozin in Patients with Chronic Kidney Disease. 
  • Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort. 
  • Enchondromatosis and Growth Plate Development. 
  • End point selection in acute decompensated heart failure clinical trials: economic end points. 
  • End points for clinical trials in acute heart failure syndromes. 
  • End-stage renal disease in nursing homes: a systematic review. 
  • Endothelial progenitor cell therapy for atherosclerosis: the philosopher's stone for an aging population? 
  • Endovascular stroke intervention in the very young. 
  • Endovenous laser ablation: strategies for treating multilevel disease. 
  • Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience. 
  • Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis. 
  • Enzalutamide in metastatic prostate cancer before chemotherapy. 
  • Epidemiologic factors and surgical outcomes in patients with nasal polyposis and asthma. 
  • Epidemiology of cardiorenal syndrome. 
  • Epidemiology of chronic kidney disease among older adults: a focus on the oldest old. 
  • Epidemiology of cognitive aging and Alzheimer's disease: contributions of the cache county utah study of memory, health and aging. 
  • Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors combined with chemotherapy in first-line treatment in an advanced non-small cell lung cancer patient with EGFR sensitive mutation. 
  • Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6. 
  • Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer. 
  • Epithelial-mesenchymal transition in cancer progression. 
  • Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives. 
  • Erythropoietin Stimulates Tumor Growth via EphB4. 
  • Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. 
  • Erythropoietin for oncology supportive care. 
  • Erythropoietin receptor contributes to melanoma cell survival in vivo. 
  • Essential role of AT1A receptor in the development of 2K1C hypertension. 
  • Estimated Glomerular Filtration Rate Variability in Patients With Heart Failure and Chronic Kidney Disease. 
  • Estimating the magnitude of clinical benefit of local therapy in patients with DCIS. 
  • Estimation and validation of a multiattribute model of Alzheimer disease progression. 
  • Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. 
  • Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI. 
  • Evaluation and treatment of dystonia. 
  • Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium. 
  • Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. 
  • Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD. 
  • Evaluation of renal function before and after percutaneous mitral valve repair. 
  • Evaluation of right and left ventricular diastolic filling. 
  • Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial. 
  • Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation. 
  • Event-based analysis of visual field change can miss fast glaucoma progression detected by a combined structure and function index. 
  • Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. 
  • Evolution of hypertrophic cardiomyopathy assessed using serial cardiovascular magnetic resonance imaging. 
  • Evolution of resistance and progression to disease during clonal expansion of cancer. 
  • Evolutionary dynamics of tumor progression with random fitness values. 
  • Evolving story of autoantibodies in systemic lupus erythematosus. 
  • Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. 
  • Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. 
  • Exercise echocardiographic comparison of pulmonary autograft and aortic homograft replacements for aortic valve disease in adults. 
  • Expanding our understanding of eye rubbing and keratoconus. 
  • Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. 
  • Expert insights: The potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer's disease and hepatic encephalopathy. 
  • Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer. 
  • Exposure to Atomic Bomb Radiation and Age-Related Macular Degeneration in Later Life: The Hiroshima-Nagasaki Atomic Bomb Survivor Study. 
  • Expression of ezrin correlates with malignant phenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells. 
  • Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. 
  • Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion. 
  • Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. 
  • Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature. 
  • Extracorporeal Membrane Oxygenation and Interfacility Transfer: A Regional Referral Experience. 
  • FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. 
  • FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit. 
  • FDG PET/CT in patients with HIV. 
  • FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study. 
  • FGFR4 does not contribute to progression of chronic kidney disease. 
  • FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling. 
  • FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast. 
  • FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy. 
  • Factors Associated With Progression to Surgical Intervention for Lumbar Disc Herniation in the Military Health System. 
  • Factors Associated with Interventions after Laser Peripheral Iridotomy for Primary Angle-Closure Spectrum Diagnoses. 
  • Factors associated with rapid progression to knee arthroplasty: complete analysis of three-year data from the osteoarthritis initiative. 
  • Factors associated with survival in the National Registry of Veterans with ALS. 
  • Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice. 
  • Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. 
  • Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. 
  • Family history of cancer and risk of sporadic differentiated thyroid carcinoma. 
  • Family instability and child maladjustment trajectories during elementary school 
  • Fatigue in HIV-Infected People: A Three-Year Observational Study. 
  • Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes. 
  • Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. 
  • Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression. 
  • Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. 
  • Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B. 
  • Fenofibrate - a potential systemic treatment for diabetic retinopathy? 
  • Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives. 
  • Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. 
  • Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. 
  • Fibroblast growth factor 23 and incident CKD in type 2 diabetes. 
  • Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. 
  • Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. 
  • Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications. 
  • Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944). 
  • Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus. 
  • Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma. 
  • Finding useful biomarkers for Parkinson's disease. 
  • First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH database. 
  • First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. 
  • First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH. 
  • Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials. 
  • Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. 
  • Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. 
  • Fluid dynamics of ventricular filling in heart failure: overlooked problems of RV/LV chamber dilatation. 
  • Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. 
  • Fluoxetine in child and adolescent depression: acute and maintenance treatment. 
  • Force-pain relationship in functional magnetic and electrical stimulation of subjects with paresis and preserved sensation. 
  • Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials. 
  • Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis. 
  • Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy. 
  • Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis. 
  • Foveal Differentiation and Inner Retinal Displacement Are Arrested in Extremely Premature Infants. 
  • Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group. 
  • Frequency, timing, and predictors of neurological dysfunction in the nonmyelopathic patient with cervical spinal cord compression, canal stenosis, and/or ossification of the posterior longitudinal ligament. 
  • Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. 
  • From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. 
  • Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms. 
  • Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. 
  • Functional Mitral Regurgitation: Appraising the Evidence Behind Recommended Treatment Strategies. 
  • Functional joint model for longitudinal and time-to-event data: an application to Alzheimer's disease. 
  • Functional outcomes for clinical trials in frail older persons: time to be moving. 
  • Functional signature of conversion of patients with mild cognitive impairment. 
  • Functional survival forests for multivariate longitudinal outcomes: Dynamic prediction of Alzheimer's disease progression. 
  • Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx. 
  • Fundus autofluorescence imaging in age-related macular degeneration and geographic atrophy. 
  • GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease. 
  • GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. 
  • GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study. 
  • Gastroesophageal reflux-associated aspiration alters the immune response in asthma. 
  • Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. 
  • Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B. 
  • Gender differences in survival in advanced heart failure. Insights from the FIRST study. 
  • Gene Expression Profiling of Bronchoalveolar Lavage Cells During Aspergillus Colonization of the Lung Allograft. 
  • Gene Expression Signatures and the Spectrum of Coronary Artery Disease. 
  • Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. 
  • Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma. 
  • Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parents. 
  • Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. 
  • Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease. 
  • Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study. 
  • Genetic alterations in prostate adenocarcinoma. 
  • Genetic background influences cardiac phenotype in murine chronic kidney disease. 
  • Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. 
  • Genetic heterogeneity of Alzheimer's disease in subjects with and without hypertension. 
  • Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. 
  • Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. 
  • Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy. 
  • Genital Hiatus Size as a Predictor of Progression of Pelvic Organ Prolapse. 
  • Genome-wide association study on progression of carotid artery intima media thickness over 10 years in a Chinese cohort. 
  • Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. 
  • Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium. 
  • Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors. 
  • Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. 
  • Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. 
  • Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma. 
  • Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease. 
  • Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. 
  • Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events. 
  • Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. 
  • Global metabolic profiling of human osteoarthritic synovium. 
  • Global role of the immune system in identifying cancer initiation and limiting disease progression. 
  • Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis. 
  • Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? 
  • Glyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice. 
  • Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis. 
  • Gradient hydrogels for screening stiffness effects on patient-derived glioblastoma xenograft cellfates in 3D. 
  • Great saphenous vein stump thrombosis after harvesting for coronary artery bypass graft surgery. 
  • Growth patterns reflect response to antiretroviral therapy in HIV-positive infants: potential utility in resource-poor settings. 
  • Growth-friendly Spinal Instrumentation in Marfan Syndrome Achieves Sustained Gains in Thoracic Height Amidst High Rates of Implant Failure. 
  • Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure. 
  • Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. 
  • Gut microbes out of control in HIV infection. 
  • H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine. 
  • HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression. 
  • HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group. 
  • HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C. 
  • HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. 
  • HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. 
  • Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. 
  • Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity. 
  • Hazard of incident and progressive knee and hip radiographic osteoarthritis and chronic joint symptoms in individuals with and without limb length inequality. 
  • Head-to-head comparison of the Lyon Schuss and fixed flexion radiographic techniques. Long-term reproducibility in normal knees and sensitivity to change in osteoarthritic knees. 
  • Headaches, rapidly progressive visual loss, and bilateral disc edema. 
  • Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancer. 
  • Heart failure drug treatment. 
  • Heart failure in elderly patients: distinctive features and unresolved issues. 
  • Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Heart rate is associated with progression of atrial fibrillation, independent of rhythm. 
  • Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. 
  • Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism. 
  • Hemodynamic and morphological characteristics of a growing cerebral aneurysm. 
  • Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). 
  • Hepatic complications of obesity. 
  • Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. 
  • Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. 
  • Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults. 
  • Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin. 
  • Hepatitis C and steatosis. 
  • Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. 
  • Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. 
  • Hepatobiliary phase hypointensity predicts progression to hepatocellular carcinoma for intermediate-high risk observations, but not time to progression. 
  • Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up. 
  • Herpes virus infections, HIV, and disease progression. Guarded optimism. 
  • Heterogeneity in Blood Pressure Transitions Over the Life Course: Age-Specific Emergence of Racial/Ethnic and Sex Disparities in the United States. 
  • Heterogeneity in the three-year course of major depression among older adults. 
  • Heterogeneous Outcomes of Heart Failure with Better Ejection Fraction. 
  • Hidden biases in an observational study of bevacizumab beyond progression. 
  • Hierarchical cognitive control deficits following damage to the human frontal lobe. 
  • High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization. 
  • High yield reproducible rat model recapitulating human Barrett's carcinogenesis. 
  • High-LET Radiation Increases Tumor Progression in a K-Ras-Driven Model of Lung Adenocarcinoma. 
  • High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study. 
  • High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer. 
  • High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. 
  • Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. 
  • Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. 
  • Hindfoot Arthritis Progression and Arthrodesis Risk After Total Ankle Replacement. 
  • Hippocampus atrophy and the longitudinal course of late-life depression. 
  • Histologically benign, clinically aggressive: Progressive non-optic pathway pilocytic astrocytomas in adults with NF1. 
  • Historical controls in ALS trials: a high seas rescue? 
  • Hodgkin lymphoma. 
  • Holding back the sea: the role for maintenance chemotherapy in metastatic breast cancer. 
  • Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy. 
  • Hormone naïve prostate cancer: predicting and maximizing response intervals. 
  • Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. 
  • Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma. 
  • How common are ALS plateaus and reversals? 
  • How common is misdiagnosis in late-onset Pompe disease? 
  • How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. 
  • Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. 
  • Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. 
  • Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression. 
  • Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. 
  • Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study. 
  • Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. 
  • Hyperperfusion on perfusion computed tomography following revascularization for acute stroke. 
  • Hypertonic hyperglycemia progresses to diabetes faster than normotonic hyperglycemia. 
  • Hypochloremia, Diuretic Resistance, and Outcome in Patients With Acute Heart Failure. 
  • Hypothesis: Presymptomatic treatment of Sturge-Weber Syndrome With Aspirin and Antiepileptic Drugs May Delay Seizure Onset. 
  • Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change. 
  • Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. 
  • ICG angiography predicts burn scarring within 48 h of injury in a porcine vertical progression burn model. 
  • IDH1 and IDH2 mutations in gliomas. 
  • IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils. 
  • INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure. 
  • IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. 
  • Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-Terminus. 
  • Identification of clusters of rapid and slow decliners among subjects at risk for Alzheimer's disease. 
  • Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials. 
  • Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes. 
  • Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. 
  • Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. 
  • If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD). 
  • IgA transcytosis and antigen recognition govern ovarian cancer immunity. 
  • Images in clinical medicine. Rapid progression of basal-type breast cancer. 
  • Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5. 
  • Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ. 
  • Imaging surrogate end points in heart failure trials. 
  • Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. 
  • Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques. 
  • Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. 
  • Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression. 
  • Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma. 
  • Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. 
  • Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly. 
  • Impact of Artifacts From Optical Coherence Tomography Retinal Nerve Fiber Layer and Macula Scans on Detection of Glaucoma Progression. 
  • Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan. 
  • Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. 
  • Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection. 
  • Impact of Incidence and Progression of Diabetic Retinopathy on Vision-Specific Functioning. 
  • Impact of Low Carbohydrate Diet on Self-Report Fatigue and Weakness in Prostate Cancer Patients. 
  • Impact of a recombinant fowlpox vaccine on the efficacy of adoptive cell therapy with tumor infiltrating lymphocytes in a patient with metastatic melanoma. 
  • Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. 
  • Impact of acute kidney injury on chronic kidney disease and its progression. 
  • Impact of anxiety and depression on progression to glaucoma among glaucoma suspects. 
  • Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. 
  • Impact of glaucoma severity and laterality on vision-specific functioning: the Singapore Malay eye study. 
  • Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative. 
  • Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS). 
  • Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. 
  • Impacts of depression and emotional distress on cardiac disease. 
  • Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss. 
  • Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives. 
  • Implications of Using Different Definitions on Outcomes in Worsening Heart Failure. 
  • Importance of Sagittal Alignment of the Cervical Spine in the Management of Degenerative Cervical Myelopathy. 
  • Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. 
  • Improved Detection of Visual Field Progression Using a Spatiotemporal Boundary Detection Method. 
  • Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study. 
  • Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma. 
  • Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF. 
  • Improvement of bilateral ptosis on higher dose enzyme replacement therapy in Pompe disease. 
  • Improvements in health-related quality of life following a group intervention for coping with AIDS-bereavement among HIV-infected men and women. 
  • Improving the quality of survivorship for older adults with cancer. 
  • In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database. 
  • In vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell movements in embryonal rhabdomyosarcoma. 
  • In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization. 
  • In-hospital worsening heart failure. 
  • Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. 
  • Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial. 
  • Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study). 
  • Incidence of Acute, Progressive, and Delayed Proximal Junctional Kyphosis Over an 8-Year Period in Adult Spinal Deformity Patients. 
  • Incidence of Glaucoma Progression and Rate of Visual Field Deterioration in a Cohort of Urban Ghanaians. 
  • Incidence of dementia and cognitive impairment, not dementia in the United States. 
  • Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction. 
  • Incidence, mode, and location of acute proximal junctional failures after surgical treatment of adult spinal deformity. 
  • Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. 
  • Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression. 
  • Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression. 
  • Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP. 
  • Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. 
  • Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults. 
  • Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys. 
  • Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. 
  • Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children. 
  • Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition. 
  • Independent data monitoring committees: an update and overview. 
  • Indications for routine repeat head computed tomography (CT) stratified by severity of traumatic brain injury. 
  • Indium lung disease. 
  • Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration. 
  • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. 
  • Infliximab for the treatment of early rheumatoid arthritis. 
  • Infliximab in active early rheumatoid arthritis. 
  • Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). 
  • Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial. 
  • Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease. 
  • Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction. 
  • Influence of host genotype on progression to acquired immunodeficiency syndrome among children infected with human immunodeficiency virus type 1. 
  • Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy. 
  • Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. 
  • Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients. 
  • Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression. 
  • Inhalational, gastrointestinal, and cutaneous anthrax in children: a systematic review of cases: 1900 to 2005. 
  • Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. 
  • Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. 
  • Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments. 
  • Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial. 
  • Insulin resistance and steatosis in hepatitis C virus infection. 
  • Insulin resistance independently predicts the progression of coronary artery calcification. 
  • Insurance status is associated with acuity of presentation and outcomes for thoracic aortic operations. 
  • International Classification of Retinopathy of Prematurity, Third Edition. 
  • Interobserver agreement and intraobserver reproducibility of the subjective determination of glaucomatous visual field progression. 
  • Interpreting measures of treatment effect in cancer clinical trials. 
  • Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. 
  • Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. 
  • Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 
  • Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma. 
  • Intratumor heterogeneity in evolutionary models of tumor progression. 
  • Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. 
  • Intratumoral inflammation is associated with more aggressive prostate cancer. 
  • Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. 
  • Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. 
  • Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria. 
  • Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap. 
  • Investigational therapies for non-muscle invasive bladder cancer. 
  • Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. 
  • Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. 
  • Irinotecan therapy in adults with recurrent or progressive malignant glioma. 
  • Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. 
  • Is Myopia Associated with the Incidence and Progression of Diabetic Retinopathy? 
  • Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment. 
  • Is bronchial thermoplasty cost-effective as treatment for problematic asthma patients? Singapore's perspective on a global model. 
  • Is it possible to slow the progression of myopia? 
  • Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial. 
  • Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. 
  • Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? 
  • Is there a link between passive smoke exposure and early-onset myopia in preschool Asian children? 
  • Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction. 
  • Isolated Noncompaction of the Left Ventricle in Adults. 
  • Joint model for survival and multivariate sparse functional data with application to a study of Alzheimer's Disease. 
  • Joint modeling of multiple repeated measures and survival data using multidimensional latent trait linear mixed model. 
  • KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance. 
  • Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. 
  • Ki67 predicts progression in early CIN: validation of a multivariate progression-risk model. 
  • Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis. 
  • Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. 
  • Knee osteoarthritis radiographic progression and associations with pain and function prior to knee arthroplasty: a multicenter comparative cohort study. 
  • LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases. 
  • LGR5 in Barrett's Esophagus and its Utility in Predicting Patients at Increased Risk of Advanced Neoplasia. 
  • LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression. 
  • LONGITUDINAL CHANGES IN THE OPTIC NERVE HEAD AND RETINA OVER TIME IN VERY YOUNG CHILDREN WITH FAMILIAL EXUDATIVE VITREORETINOPATHY. 
  • Label propagation defines signaling networks associated with recurrently mutated cancer genes. 
  • Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol. 
  • Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. 
  • Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. 
  • Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. 
  • Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre. 
  • Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial. 
  • Large anterior mediastinal mass in an infant. 
  • Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. 
  • Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. 
  • Large-Scale Analysis of Breast Cancer-Related Conformational Changes in Proteins Using SILAC-SPROX. 
  • Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial. 
  • Late "adult form" scimitar syndrome presenting with "infant form" complications. 
  • Late growth of infantile hemangiomas in children >3 years of age: A retrospective study. 
  • Late onset Pompe Disease in India - Beyond the Caucasian phenotype. 
  • Late onset of isolated central nervous system metastasis of liposarcoma--a case report. 
  • Late-Life Cognitive Trajectories and their Associated Lifestyle Factors. 
  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. 
  • Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. 
  • Left ventricular long axis function assessed during cine-cardiovascular magnetic resonance is an independent predictor of adverse cardiac events. 
  • Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis. 
  • Leptin and ghrelin in relation to Helicobacter pylori status in adult males. 
  • Leukaemia hijacks a neural mechanism to invade the central nervous system. 
  • Leukemia cutis in a patient with chronic neutrophilic leukemia. 
  • Lifetime comorbidity, lifetime history of psychosis and suicide attempts, and current symptoms of patients with deteriorated affective disorder. 
  • Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. 
  • Links between anxiety and allergies: psychobiological reality or possible methodological bias? 
  • Lipomatosis of Nerve and Neuromuscular Choristoma: Two Rare Entities and Their Call for an Animal Model to Understand and Mitigate Nerve-Territory Sequelae. 
  • Lithium may slow progression of amyotrophic lateral sclerosis, but further study is needed. 
  • Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates. 
  • Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. 
  • Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. 
  • Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression. 
  • Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. 
  • Long-Term Outcomes of 125 Patients With Metastatic Pheochromocytoma or Paraganglioma Treated With 131-I MIBG. 
  • Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation. 
  • Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up. 
  • Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. 
  • Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. 
  • Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara. 
  • Long-term follow-up of retinal nerve fiber layer cleavages in glaucoma patients and suspects. 
  • Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment. 
  • Long-term health and social function in adult survivors of paediatric astrocytoma: A report from the Childhood Cancer Survivor Study. 
  • Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial. 
  • Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure. 
  • Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL. 
  • Long-term safety and efficacy of eculizumab in generalized myasthenia gravis. 
  • Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. 
  • Long-term structural and functional outcomes of primary congenital glaucoma. 
  • Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial. 
  • Longitudinal Association Between Hearing Loss, Vision Loss, Dual Sensory Loss, and Cognitive Decline. 
  • Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. 
  • Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients. 
  • Longitudinal Study of Visual Function in Dry Age-Related Macular Degeneration at 12 Months. 
  • Longitudinal analysis of reticular drusen associated with geographic atrophy in age-related macular degeneration. 
  • Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers. 
  • Longitudinal changes in central corneal thickness and their relation to glaucoma status: an 8 year follow up study. 
  • Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: the Flint Men's Health Study. 
  • Longitudinal dimensionality of adolescent psychopathology: testing the differentiation hypothesis. 
  • Longitudinal evaluation of economic and physical impact of Parkinson's disease. 
  • Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. 
  • Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease. 
  • Longitudinal molecular trajectories of diffuse glioma in adults. 
  • Longitudinal reproducibility of optical coherence tomography measurements in children. 
  • Longitudinal validation of periarticular bone area and 3D shape as biomarkers for knee OA progression? Data from the FNIH OA Biomarkers Consortium. 
  • Longitudinal visual field variability and the ability to detect glaucoma progression in black and white individuals. 
  • Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression. 
  • Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets. 
  • Loss of HNF6 expression correlates with human pancreatic cancer progression. 
  • Loss of KAI1 expression in the progression of colorectal cancer. 
  • Loss of basal cells precedes bronchiolitis obliterans-like pathological changes in a murine model of chlorine gas inhalation. 
  • Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. 
  • Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer. 
  • Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. 
  • Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. 
  • Loss of the tumor suppressor, Tp53, enhances the androgen receptor-mediated oncogenic transformation and tumor development in the mouse prostate. 
  • Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. 
  • Low lead one ratio predicts clinical outcomes in left bundle branch block. 
  • Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology. 
  • Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. 
  • Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers. 
  • Lower abdominal and pelvic pain with advanced pelvic organ prolapse: a case-control study. 
  • Luminal alkalinization attenuates proteinuria-induced oxidative damage in proximal tubular cells. 
  • Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial. 
  • Lung transplantation in advanced COPD: is it worth it? 
  • Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. 
  • Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. 
  • Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases. 
  • Lymphocyte responses exacerbate angiotensin II-dependent hypertension. 
  • Lysyl oxidase is essential for hypoxia-induced metastasis. 
  • M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice. 
  • MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression. 
  • MSH6 inactivation and emergent temozolomide resistance in human glioblastomas. 
  • MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition. 
  • MYOPIC RETINOSCHISIS IN ASIANS: Structural Features and Determinants of Visual Acuity and Prognostic Factors for Progression. 
  • Macular thickness and aging in retinitis pigmentosa. 
  • Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. 
  • Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study. 
  • Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer. 
  • Major depression and physical illness trajectories in heart failure and pulmonary disease. 
  • Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. 
  • Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. 
  • Malignant transformation of iris melanocytoma to iris ring melanoma. 
  • Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum. 
  • Management of Idiopathic Pulmonary Fibrosis. 
  • Management of ductal carcinoma in situ. 
  • Management of intrinsic gliomas of the tectal plate in children. A ten-year review. 
  • Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. 
  • Managing Patients With Oligometastatic Non-Small-Cell Lung Cancer. 
  • Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. 
  • Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases. 
  • Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance). 
  • Masked Hypertension and Incident Clinic Hypertension Among Blacks in the Jackson Heart Study. 
  • Masson's tumor of the pineal region: case report. 
  • Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. 
  • Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials. 
  • Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells. 
  • Mechanisms of disease progression in NASH: new paradigms. 
  • Mechanisms of disease progression in nonalcoholic fatty liver disease. 
  • Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. 
  • Medical management of venous ulcers. 
  • Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy. 
  • Memory complaint is not necessary for diagnosis of mild cognitive impairment and does not predict 10-year trajectories of functional disability, word recall, or short portable mental status questionnaire limitations. 
  • Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer. 
  • Metabolic syndrome predicts mobility decline in a community-based sample of older adults. 
  • Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclines. 
  • MicroRNA expression characterizes oligometastasis(es). 
  • MicroRNAs relate to early worsening of renal function in patients with acute heart failure. 
  • Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. 
  • Mild cognitive impairment and 10-year trajectories of disability in the Iowa Established Populations for Epidemiologic Studies of the Elderly cohort. 
  • Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. 
  • Mineral metabolites and CKD progression in African Americans. 
  • Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. 
  • Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension. 
  • Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer. 
  • Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis. 
  • Mixed messages on systemic therapies for diabetic retinopathy. 
  • Modeling cancer progression via pathway dependencies. 
  • Modeling community COVID-19 transmission risk associated with U.S. universities. 
  • Modeling the natural history of ductal carcinoma in situ based on population data. 
  • Modest exercise prevents the progressive disease associated with physical inactivity. 
  • Molecular Biology and Evolution of Cancer: From Discovery to Action. 
  • Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies. 
  • Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. 
  • Molecular characterization of the tumor-suppressive function of nischarin in breast cancer. 
  • Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. 
  • Molecular classification of cutaneous malignant melanoma by gene expression profiling. 
  • Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors. 
  • Molecular markers in bladder cancer. 
  • Monitoring radiographic brain tumor progression. 
  • Monoclonal B cell lymphocytosis: clinical and population perspectives. 
  • Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. 
  • Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations. 
  • Most Gleason 8 Biopsies are Downgraded at Prostatectomy-Does 4 + 4 = 7? 
  • Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy. 
  • Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. 
  • Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence? 
  • Multidimensional latent trait linear mixed model: an application in clinical studies with multivariate longitudinal outcomes. 
  • Multidisciplinary Management of Breast Cancer Brain Metastases. 
  • Multimodal manifold-regularized transfer learning for MCI conversion prediction. 
  • Multimorbidity in patients with monoclonal gammopathy of undetermined significance. 
  • Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. 
  • Multiple myeloma, version 1.2013. 
  • Multiple myeloma. 
  • Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy. 
  • Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages. 
  • Multivariable Modeling of Biomarker Data From the Phase I Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. 
  • Multivariate MR biomarkers better predict cognitive dysfunction in mouse models of Alzheimer's disease. 
  • Multivariate functional mixed model with MRI data: An application to Alzheimer's disease. 
  • Myelodysplastic syndromes in the United States: an update for clinicians. 
  • Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial. 
  • Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management. 
  • N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN. 
  • N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. 
  • NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition. 
  • NASH and cryptogenic cirrhosis: a histological analysis. 
  • NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. 
  • NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia. 
  • NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. 
  • Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination. 
  • Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17. 
  • Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study). 
  • Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas. 
  • Natural Progression of Canine Glycogen Storage Disease Type IIIa. 
  • Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation. 
  • Natural history of central sparing in geographic atrophy secondary to non-exudative age-related macular degeneration. 
  • Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. 
  • Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families. 
  • Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. 
  • Natural history of penetrating atherosclerotic ulcers in aortic branch vessels. 
  • Navigating prognostic communication when children with poor-prognosis cancer experience prolonged disease stability. 
  • Necrotizing enterocolitis and the use of loop diuretics in very low birth weight neonates. 
  • Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results. 
  • Neoadjuvant hormone therapy: the Canadian trials. 
  • Neonatal co-infection with helicobacter species markedly accelerates the development of inflammation-associated colonic neoplasia in IL-10(-/-) mice. 
  • Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). 
  • Net endogenous acid production is associated with a faster decline in GFR in African Americans. 
  • Neurocognitive dysfunction following cardiac surgery. 
  • Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. 
  • Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. 
  • Neuroimaging and the search for a cure for Alzheimer disease. 
  • Neuroinflammation in Alzheimer's disease. 
  • Neuromyelitis optica: Clinical course and potential prognostic indicators. 
  • Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. 
  • Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. 
  • Neuropsychological assessment of Alzheimer's disease. 
  • Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. 
  • Neuropsychological indicators of preclinical Alzheimer's disease among depressed older adults. 
  • Neuropsychological predictors of dementia in late-life major depressive disorder. 
  • Neuroticism Traits Selectively Impact Long Term Illness Course and Cognitive Decline in Late-Life Depression. 
  • Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection. 
  • Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. 
  • Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database. 
  • New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma. 
  • New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. 
  • New onset and remission of suicidal ideation among a depressed adult sample. 
  • New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality. 
  • Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial. 
  • Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results. 
  • Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. 
  • No heroic measures: how soon is too soon to stop? 
  • No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. 
  • Nomenclature in heart failure: a call for objective, reproducible, and biologically-driven terminology. 
  • Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. 
  • Non-alcoholic steatohepatitis pathogenesis: role of repair in regulating the disease progression. 
  • Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern? 
  • Nonalcoholic fatty liver disease: an agenda for clinical research. 
  • Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis. 
  • Nondepressive Psychosocial Factors and CKD Outcomes in Black Americans. 
  • Nonoperative management of rectal cancer: current perspectives. 
  • Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study. 
  • Notch signaling in postnatal joint chondrocytes, but not subchondral osteoblasts, is required for articular cartilage and joint maintenance. 
  • Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease. 
  • Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors. 
  • OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA. 
  • OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study. 
  • OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. 
  • Obesity and altered angiogenic-related gene expression in endometrial cancer. 
  • Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. 
  • Observational study of subclinical diabetic macular edema. 
  • Observations on the growth of loose bodies in joints. 
  • Observations on the transition from intermittent to permanent atrial fibrillation. 
  • Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. 
  • Oligoreview of Non-Small Cell Lung Cancer Oligometastases. 
  • On the interplay of telomeres, nevi and the risk of melanoma. 
  • Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma. 
  • Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression. 
  • Onset and persistence of postpartum depression in an inner-city maternal health clinic system. 
  • Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer. 
  • Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. 
  • Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. 
  • Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis. 
  • Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series. 
  • Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis. 
  • Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration. 
  • Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration. 
  • Optimal lesion number for evaluation of tumor response in response evaluation criteria in solid tumors. 
  • Optimal therapy for desmoid tumors: current options and challenges for the future. 
  • Optimal use of radium-223 in patients with metastatic castration-resistant prostate cancer. 
  • Optimal weight in estimating and comparing areas under the receiver operating characteristic curve using longitudinal data. 
  • Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. 
  • Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial. 
  • Orbital recurrence of B-progenitor acute lymphoblastic leukemia in a child. 
  • Oropharyngeal dysphagia in infants and children with infantile Pompe disease. 
  • Osteonecrosis of the human skeleton. 
  • Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice. 
  • Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction. 
  • Outcomes in pediatric patients with Chiari malformation Type I followed up without surgery. 
  • Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis. 
  • Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study. 
  • Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry. 
  • Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial. 
  • Outpatient Worsening Heart Failure as a Target for Therapy: A Review. 
  • Outpatient versus observation/inpatient management of emergency department patients rapidly ruled-out for acute myocardial infarction: Findings from the HIGH-US study. 
  • Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. 
  • Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids. 
  • PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma. 
  • PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. 
  • PEDF deficiency increases the susceptibility of rd10 mice to retinal degeneration. 
  • PERIVASCULAR THICKENING ON OPTICAL COHERENCE TOMOGRAPHY AS A MARKER OF INFLAMMATION IN BIRDSHOT RETINOCHOROIDITIS. 
  • PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart. 
  • PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. 
  • PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. 
  • PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium. 
  • PTEN gene mutations are seen in high-grade but not in low-grade gliomas. 
  • Pacemaker-induced transient asynchrony suppresses heart failure progression. 
  • Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study. 
  • Pain, stiffness, and fatigue in juvenile polyarticular arthritis: contemporaneous stressful events and mood as predictors. 
  • Palliative treatment of dysphonia and dysarthria. 
  • Pancreatitis complicated by gland necrosis: evolution of findings on contrast-enhanced CT. 
  • Pancreatitis: the acid test. 
  • Paraquat ingestion: a challenging diagnosis. 
  • Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia. 
  • Pathogenesis and Cells of Origin of Barrett's Esophagus. 
  • Pathogenesis and treatment of osteoarthritis. 
  • Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. 
  • Pathogenesis of Nonalcoholic Steatohepatitis. 
  • Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction. 
  • Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. 
  • Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. 
  • Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19. 
  • Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis. 
  • Patient Education and Support During CKD Transitions: When the Possible Becomes Probable. 
  • Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study. 
  • Patient education level as a predictor of survival in lung cancer clinical trials. 
  • Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. 
  • Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis. 
  • Patients Commonly Believe Their Heart Failure Hospitalizations Are Preventable and Identify Worsening Heart Failure, Nonadherence, and a Knowledge Gap as Reasons for Admission. 
  • Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life. 
  • Patients with asthma demonstrate airway inflammation after exposure to concentrated ambient particulate matter. 
  • Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis. 
  • Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer. 
  • Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. 
  • Patterns of response and progression in bone and soft tissue during and after treatment with radium-223 for metastatic castrate-resistant prostate cancer. 
  • Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. 
  • Percent tumor involvement and risk of biochemical progression after radical prostatectomy. 
  • Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey-Based Study. 
  • Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. 
  • Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation. 
  • Performance of a non-fluoroscopically assisted substitute for the Lyon schuss knee radiograph: quality and reproducibility of positioning and sensitivity to joint space narrowing in osteoarthritic knees. 
  • Performance of the Rule of 5 for Detecting Glaucoma Progression between Visits with OCT. 
  • Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis. 
  • Peripheral serum metabolomic profiles inform central cognitive impairment. 
  • Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events. 
  • Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study. 
  • Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury. 
  • Persistent pulmonary subsolid nodules with solid portions of 5 mm or smaller: Their natural course and predictors of interval growth. 
  • Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes. 
  • Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. 
  • Perspective: Untangling the ALS X-Files. 
  • Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer. 
  • Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. 
  • Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. 
  • Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analyses. 
  • Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma. 
  • Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors. 
  • Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response. 
  • Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. 
  • Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors. 
  • Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. 
  • Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer. 
  • Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. 
  • Phase II evaluation of oral estramustine, oral etoposide, and intravenous paclitaxel in patients with hormone-sensitive prostate adenocarcinoma. 
  • Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme. 
  • Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. 
  • Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. 
  • Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207. 
  • Phase II study of carboplatin in children with progressive low-grade gliomas. 
  • Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium. 
  • Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme. 
  • Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. 
  • Phase II study of single-agent orteronel (TAK-700) in patients with nonmetastatic castration-resistant prostate cancer and rising prostate-specific antigen. 
  • Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib. 
  • Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck. 
  • Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. 
  • Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial. 
  • Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer. 
  • Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. 
  • Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy. 
  • Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer. 
  • Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. 
  • Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer. 
  • Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial. 
  • Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program. 
  • Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation. 
  • Phlebitis, pulmonary emboli and presidential politics: Richard M. Nixon's complicated deep vein thrombosis. 
  • Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. 
  • Physical Activity to Prevent and Treat Hypertension: A Systematic Review. 
  • Pik3c3 deletion in pyramidal neurons results in loss of synapses, extensive gliosis and progressive neurodegeneration. 
  • Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C. 
  • Plasma cell problems: Case 1. Disseminated cutaneous plasmacytomas treated with total skin electron radiotherapy. 
  • Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis. 
  • Platinum sensitivity in metastatic prostate cancer: does histology matter? 
  • Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms. 
  • Plenary session on aging and biology: effects on growth and plasticity through the lifespan. Physical Disabilities through the Lifespan Conference. 
  • Podocyte biology in segmental sclerosis and progressive glomerular injury. 
  • Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression. 
  • Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. 
  • Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. 
  • Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. 
  • Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. 
  • Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. 
  • Polyvascular Disease: Reappraisal of the Current Clinical Landscape. 
  • Pompe disease in infants: improving the prognosis by newborn screening and early treatment. 
  • Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases. 
  • Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. 
  • Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. 
  • Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer. 
  • Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. 
  • Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. 
  • Postoperative Acute Kidney Injury Is Associated With Progression of Chronic Kidney Disease Independent of Severity. 
  • Postoperative prognosis prediction of pancreatic cancer with seven microRNAs. 
  • Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. 
  • Potential additional indicators for pacemaker requirement in isolated congenital atrioventricular block. 
  • Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. 
  • Potential role of granulocyte-monocyte colony-stimulating factor in the progression of intracranial aneurysms. 
  • Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR+/HER2- Breast Cancer. 
  • Practice-based differences in paediatric discoid lupus erythematosus. 
  • Predicting 6- and 12-Month Risk of Mortality in Patients With Platinum-Resistant Advanced-Stage Ovarian Cancer: Prognostic Model to Guide Palliative Care Referrals. 
  • Predicting Parkinson's disease trajectory using clinical and neuroimaging baseline measures. 
  • Predicting disease progression after regional therapy for in-transit melanoma. 
  • Predicting prognosis for the conduct-problem boy: can family history help? 
  • Predicting risk of diabetic retinopathy from retinal vessel analysis: personalized medicine in transition. 
  • Predicting the Development of Reduced Left Ventricular Ejection Fraction in Patients With Left Bundle Branch Block. 
  • Predicting the Risk of Huntington's Disease with Multiple Longitudinal Biomarkers. 
  • Predicting the trajectories of depressive symptoms among southern community-dwelling older adults: the role of religiosity. 
  • Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database. 
  • Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL. 
  • Prediction of cognitive decline in early Alzheimer's disease. 
  • Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma. 
  • Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial. 
  • Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE-HF extended trial. 
  • Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer. 
  • Prediction, progression, and outcomes of chronic kidney disease in older adults. 
  • Predictive Utility of Marketed Volumetric Software Tools in Subjects at Risk for Alzheimer Disease: Do Regions Outside the Hippocampus Matter? 
  • Predictive Validity of Radiographic Trabecular Bone Texture in Knee Osteoarthritis: The Osteoarthritis Research Society International/Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. 
  • Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium. 
  • Predictive value of pre-plus disease in retinopathy of prematurity. 
  • Predictors and progression of aortic stenosis in patients with preserved left ventricular ejection fraction. 
  • Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. 
  • Predictors of Outcome in Ulcerative Colitis. 
  • Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study. 
  • Predictors of disease progression in pediatric dilated cardiomyopathy. 
  • Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. 
  • Predictors of late neurological deterioration after spontaneous intracerebral hemorrhage. 
  • Predictors of patients who present to the emergency department with sepsis and progress to septic shock between 4 and 48 hours of emergency department arrival. 
  • Predictors of progression of scoliosis after decompression of an Arnold Chiari I malformation. 
  • Predictors of response to physical therapy intervention in patients with primary hip osteoarthritis. 
  • Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. 
  • Predictors of weight loss in Parkinson's disease. 
  • Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. 
  • Preeclampsia into eclampsia: toward a new paradigm. 
  • Pregnancy and myasthenia gravis. 
  • Prehypertension: to treat or not to treat should no longer be the question. 
  • Preliminary Clinical and Molecular Analysis Results From a Single-Arm Phase 2 Trial of Brigatinib in Patients With Disease Progression After Next-Generation ALK Tyrosine Kinase Inhibitors in Advanced ALK+ NSCLC. 
  • Premature ventricular contraction-induced cardiomyopathy in children. 
  • Premorbid personality predicts level of rated personality change in patients with Alzheimer disease. 
  • Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure. 
  • Presentation and Progression of Papilledema in Cerebral Venous Sinus Thrombosis. 
  • Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. 
  • Prevalence of cognitive impairment without dementia in the United States. 
  • Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. 
  • Prevalence, severity, and impact of foraminal and canal stenosis among adults with degenerative scoliosis. 
  • Preventing Alzheimer's disease and cognitive decline. 
  • Prevention of acute exacerbation of chronic obstructive pulmonary disease after bronchoscopic lung volume reduction with endobronchial valves. 
  • Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry. 
  • Primary Medical Care Integrated with Healthy Eating and Healthy Moving is Essential to Reduce Chronic Kidney Disease Progression. 
  • Primary care-specialist collaboration in the care of patients with chronic kidney disease. 
  • Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data. 
  • Primary hormonal therapy for prostate cancer: experience with 135 consecutive PSA-ERA patients from a tertiary care military medical center. 
  • Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. 
  • Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma. 
  • Primum non nocere (first do no harm): symptom worsening and improvement in female assault victims after prolonged exposure for PTSD. 
  • Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging. 
  • Principles of screening for chronic kidney disease. 
  • Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis. 
  • Progenitor Hyperpolarization Regulates the Sequential Generation of Neuronal Subtypes in the Developing Neocortex. 
  • Progestin therapy of complex endometrial hyperplasia with and without atypia. 
  • Prognosis after change in left ventricular ejection fraction during mental stress testing in patients with stable coronary artery disease. 
  • Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase. 
  • Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data. 
  • Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support. 
  • Prognostic Modeling of Parkinson's Disease Progression Using Early Longitudinal Patterns of Change. 
  • Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure. 
  • Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes. 
  • Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). 
  • Prognostic factors for survival following initiation of second-line treatment with everolimus for metastatic renal cell carcinoma: evidence from a nationwide sample of clinical practice in the United States. 
  • Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer. 
  • Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. 
  • Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. 
  • Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training. 
  • Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. 
  • Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository. 
  • Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN). 
  • Progression of Alzheimer's disease in black and white patients: the CERAD experience, part XVI. Consortium to Establish a Registry for Alzheimer's Disease. 
  • Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. 
  • Progression of Treated versus Untreated Liver Imaging Reporting and Data System Category 4 Masses after Transcatheter Arterial Embolization Therapy. 
  • Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation. 
  • Progression of alternating hemiplegia of childhood-related focal epilepsy to electrical status epilepticus in sleep with reversible encephalopathy. 
  • Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. 
  • Progression of choroidal neovascularization following injection of pegaptanib sodium (macugen) in two eyes with neovascular age-related macular degeneration. 
  • Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. 
  • Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. 
  • Progression of diabetic retinopathy in the hypertension intervention nurse telemedicine study. 
  • Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. 
  • Progression of idiopathic pulmonary fibrosis in native lungs after single lung transplantation. 
  • Progression of impairment in patients with vascular cognitive impairment without dementia. 
  • Progression of mass effect after intracerebral hemorrhage. 
  • Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing. 
  • Progression of renal artery stenosis in patients undergoing cardiac catheterization. 
  • Progression of renal tumors after laparoscopic radiofrequency ablation. 
  • Progression of subcortical ischemic disease from vascular depression to vascular dementia. 
  • Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. 
  • Progression to AIDS: the effects of stress, depressive symptoms, and social support. 
  • Progression-free survival as a predictor of overall survival in men with castrate-resistant prostate cancer. 
  • Progressive Retinal Vasodilation in Patients With Type 1 Diabetes: A Longitudinal Study of Retinal Vascular Geometry. 
  • Progressive enlargement of cavity within melanoma masquerading as iris cyst. 
  • Progressive morphometric and cognitive changes in vascular dementia. 
  • Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes. 
  • Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts. 
  • Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients. 
  • Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration. 
  • Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases. 
  • Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure. 
  • Prostate Cancer Predisposition. 
  • Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel. 
  • Prostate Cancer, Version 1.2016. 
  • Prostate cancer in young men: an important clinical entity. 
  • Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression. 
  • Prostate specific antigen only progression of prostate cancer. 
  • Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone. 
  • Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer. 
  • Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. 
  • Prostatic sarcoma with rapid tumor progression after nerve sparing radical cystoprostatectomy. 
  • Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. 
  • Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. 
  • Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration. 
  • Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer. 
  • Protein Inhibitor of Activated STAT3 (PIAS3) Is Down-Regulated in Eutopic Endometrium of Women with Endometriosis. 
  • Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression. 
  • Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. 
  • Protocol for a feasibility randomised controlled trial of Screening and Enhanced Risk management for Vascular Event-related Decline in Memory (SERVED Memory). 
  • Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. 
  • Psychosocial aspects of active surveillance. 
  • Public funding of understanding nature. 
  • Pulmonary marginal zone lymphoma: a single centre experience and review of the SEER database. 
  • Pulse pressure and vascular risk in the elderly: associations and clinical implications. 
  • Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial. 
  • QOL and outcomes research in prostate cancer patients with low socioeconomic status. 
  • Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma. 
  • Quality of life and Parkinson's disease. 
  • Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature. 
  • Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. 
  • Quality of occupational history assessments in working age adults with newly diagnosed asthma. 
  • Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance). 
  • Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome. 
  • Quantification of retinal microvasculature and neurodegeneration changes in branch retinal vein occlusion after resolution of cystoid macular edema on optical coherence tomography angiography. 
  • Quantifying six-minute walk induced gait deterioration with inertial sensors in multiple sclerosis subjects. 
  • Quantitative analysis of retinal vessel attenuation in eyes with retinitis pigmentosa. 
  • Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity. 
  • RGS-GAIP-interacting protein controls breast cancer progression. 
  • RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression. 
  • RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures. 
  • Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancer. 
  • Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center. 
  • Racial differences in cognitive decline in a sample of community-dwelling older adults: the mediating role of education and literacy. 
  • Racial differences in nocturnal dipping status in diabetic kidney disease: Results from the STOP-DKD (Simultaneous Risk Factor Control Using Telehealth to Slow Progression of Diabetic Kidney Disease) study. 
  • Radiation therapy for oligometastatic non-small cell lung cancer. 
  • Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. 
  • Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. 
  • Radiographic joint damage in rheumatoid arthritis: a community-based perspective. 
  • Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer. 
  • Radiographic progression in children with polyarticular juvenile rheumatoid arthritis: a pilot study. 
  • Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL. 
  • Radiologic intervention in the acute stroke patient. 
  • Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. 
  • Radiological evidence of spontaneous spinal arthrodesis in patients with lower lumbar spondylolisthesis. 
  • Radiosurgical treatment for Ewing's sarcoma of the lumbar spine: case report. 
  • Random forest prediction of Alzheimer's disease using pairwise selection from time series data. 
  • Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma. 
  • Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer. 
  • Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study. 
  • Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance). 
  • Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study. 
  • Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance). 
  • Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study. 
  • Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732. 
  • Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. 
  • Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. 
  • Rapamycin prevents the development and progression of mutant epidermal growth factor receptor lung tumors with the acquired resistance mutation T790M. 
  • Rapid and slow progressors differ by a single MHC class I haplotype in a family of MHC-defined rhesus macaques infected with SIV. 
  • Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. 
  • Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. 
  • Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma. 
  • Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases. 
  • Rapidly progressing adenocarcinoma of the prostate presenting as prostatitis. 
  • Rapidly progressing mycotic aortic aneurysm masquerading as acute coronary syndrome. 
  • RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer. 
  • Rate of head growth decelerates and symptoms worsen in the second year of life in autism. 
  • Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. 
  • Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study. 
  • Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. 
  • Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study. 
  • Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF). 
  • Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure. 
  • Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. 
  • Re: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. 
  • Re: Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9-10 Prostate Cancer. 
  • Re: Stages and thresholds of hemodynamic failure. 
  • Re: the economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data. 
  • Recent advances in the treatment of pediatric brain tumors. 
  • Recognition and management of masked hypertension: a review and novel approach. 
  • Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure. 
  • Recurrence of heart failure symptoms after LVAD placement due to bradycardia-induced inflow obstruction. 
  • Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. 
  • Redistribution and enhanced protein kinase C-mediated phosphorylation of alpha- and gamma-adducin during renal tumor progression. 
  • Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema during the past decade. 
  • Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. 
  • Reducing CKD risks among vulnerable populations in primary care. 
  • Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. 
  • Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. 
  • Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials. 
  • Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma. 
  • Refractory myasthenia gravis exacerbation triggered By pembrolizumab. 
  • Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling. 
  • Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study. 
  • Registry studies of long-term multiple sclerosis outcomes: description of key registries. 
  • Regulation of myeloid leukaemia by the cell-fate determinant Musashi. 
  • Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. 
  • Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. 
  • Relation of lifetime trauma and depressive symptoms to mortality in HIV. 
  • Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study). 
  • Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community. 
  • Relationship Between Electrical and Mechanical Dyssynchrony and Outcomes Among Patients Undergoing Cardiac Resynchronization Therapy. 
  • Relationship between ganglion cell-inner plexiform layer and optic disc/retinal nerve fibre layer parameters in non-glaucomatous eyes. 
  • Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. 
  • Relationship between nephrologist care and progression of chronic kidney disease. 
  • Relationship between stage of kidney disease and incident heart failure in older adults. 
  • Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. 
  • Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional study. 
  • Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. 
  • Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease. 
  • Relationship of global assessment of change to AUSCAN and pinch and grip strength among individuals with hand osteoarthritis. 
  • Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease. 
  • Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12. 
  • Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts. 
  • Renal Pre-Competitive Consortium (RPC2): discovering therapeutic targets together. 
  • Renal Recovery Years After Initial Diagnosis of Hemolytic Uremic Syndrome. 
  • Renal artery stenosis: the case for conservative management. 
  • Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes. 
  • Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. 
  • Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. 
  • Repeat CT Performed Within One Month of CT Conducted in the Emergency Department for Abdominal Pain: A Secondary Analysis of Data From a Prospective Multicenter Study. 
  • Report of the national institute on aging task force on comorbidity. 
  • Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study. 
  • Research Priorities in the Secondary Prevention of Atrial Fibrillation: A National Heart, Lung, and Blood Institute Virtual Workshop Report. 
  • Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. 
  • Reserve and resilience in CKD: concept introduction and baseline results from the Physical REsilience Prediction in Advanced REnal Disease (PREPARED) study. 
  • Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. 
  • Resolution rate of isolated low-grade hydronephrosis diagnosed within the first year of life. 
  • Respiratory care year in review 2011: long-term oxygen therapy, pulmonary rehabilitation, airway management, acute lung injury, education, and management. 
  • Response to docetaxel/carboplatin in patients with hormone-refractory prostate cancer not responding to taxane-based chemotherapy. 
  • Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases. 
  • Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107. 
  • Responsiveness to Change in PROMIS(®) Measures among Children with Asthma: A Report from the PROMIS(®) Pediatric Asthma Study. 
  • Resting-state functional connectivity predicts longitudinal pain symptom change in urologic chronic pelvic pain syndrome: a MAPP network study. 
  • Retinal Vessel Geometry and the Incidence and Progression of Diabetic Retinopathy. 
  • Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. 
  • Retinal vascular calibre as a predictor of incidence and progression of diabetic retinopathy. 
  • Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
  • Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape. 
  • Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis. 
  • Retinal vessel wall signs and the 5 year incidence of age related maculopathy: the Blue Mountains Eye Study. 
  • Retinal vessels and retinopathy of prematurity. 
  • Retinopathy of prematurity: the disease process, classifications, screening, treatment, and outcomes. 
  • Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry. 
  • Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan. 
  • Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities. 
  • Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective. 
  • Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. 
  • Rheumatic Heart Disease in the Twenty-First Century. 
  • Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function. 
  • Risk Analysis and Outcomes of Postoperative Renal Failure After Aortic Valve Surgery in the United States. 
  • Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary Care. 
  • Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents. 
  • Risk Factors for Surgical Failure and Worsening Pelvic Floor Symptoms Within 5 Years After Vaginal Prolapse Repair. 
  • Risk Profiles in Heart Failure: Baseline, Residual, Worsening, and Advanced Heart Failure Risk. 
  • Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. 
  • Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration. 
  • Risk factors for progression to penetrating keratoplasty in patients with keratoconus. 
  • Risk factors: Anxiety and risk of cardiac events. 
  • Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication. 
  • Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER. 
  • Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. 
  • Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension. 
  • Role of T-cell activation in salt-sensitive hypertension. 
  • Role of TGF-β receptor III localization in polarity and breast cancer progression. 
  • Role of guanylate cyclase modulators in decompensated heart failure. 
  • Role of inflammation in nonalcoholic steatohepatitis. 
  • Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. 
  • Role of the ABL tyrosine kinases in the epithelial-mesenchymal transition and the metastatic cascade. 
  • Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases. 
  • Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies. 
  • S100A9 is not essential for disease expression in an acute (K/BxN) or chronic (CIA) model of inflammatory arthritis. 
  • SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway. 
  • SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression. 
  • SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. 
  • STAT1 drives tumor progression in serous papillary endometrial cancer. 
  • Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas. 
  • Sagittal spinopelvic parameters in children with achondroplasia: identification of 2 distinct groups. 
  • Salvage Neuroform stent-assisted coiling for recurrent giant aneurysm after waffle-cone treatment. 
  • Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. 
  • Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression. 
  • Screening adults for pre-diabetes and diabetes may be cost-saving. 
  • Screening examination of premature infants for retinopathy of prematurity. 
  • Screening for cancers of the head and neck: addressing the problem. 
  • Screening for proteinuria in US adults: a cost-effectiveness analysis. 
  • Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. 
  • Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. 
  • Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts. 
  • Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future Research. 
  • Segment Length in Cine Strain Analysis Predicts Cardiac Resynchronization Therapy Outcome Beyond Current Guidelines. 
  • Selective Sexual Dimorphisms in Musculoskeletal and Cardiopulmonary Pathologic Manifestations and Mortality Incidence in the Tumor Necrosis Factor-Transgenic Mouse Model of Rheumatoid Arthritis. 
  • Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation. 
  • Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. 
  • Semi-quantitative MRI biomarkers of knee osteoarthritis progression in the FNIH biomarkers consortium cohort - Methodologic aspects and definition of change. 
  • Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration. 
  • Semiquantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data From the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. 
  • Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study. 
  • Sequential development of human herpes virus 8-positive diffuse large B-cell lymphoma and chronic myelomonocytic leukemia in a 59 year old female patient with hemoglobin SC disease. 
  • Sequential lymphomas or clonally unrelated richter syndrome of chronic lymphocytic leukemia into mantle cell lymphoma. 
  • Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. 
  • Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development. 
  • Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value. 
  • Serine substitution of proline at codon 151 of TP53 confers gain of function activity leading to anoikis resistance and tumor progression of head and neck cancer cells. 
  • Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes. 
  • Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease. 
  • Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. 
  • Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer. 
  • Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. 
  • Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. 
  • Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study. 
  • Serum lipid profiles and aggressive prostate cancer. 
  • Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection. 
  • Serum transforming growth factor-beta 1 is not a robust biomarker of incident and progressive radiographic osteoarthritis at the hip and knee: the Johnston County Osteoarthritis Project. 
  • Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers. 
  • Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. 
  • Severe airway epithelial injury, aberrant repair and bronchiolitis obliterans develops after diacetyl instillation in rats. 
  • Severe childhood asthma exacerbations: Is treatment response variability in the genes? 
  • Severe life stress as a predictor of early disease progression in HIV infection. 
  • Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer's disease. 
  • Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. 
  • Sex differences in cardiovascular risk factors before and after the development of type 2 diabetes and risk for incident cardiovascular disease. 
  • Sex differences in progression of kidney disease in sickle cell disease. 
  • Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials Network. 
  • Sex-Related Differences in Heart Failure With Preserved Ejection Fraction. 
  • Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors. 
  • Short-Term Changes in Cardiorespiratory Fitness in Response to Exercise Training and the Association with Long-Term Cardiorespiratory Fitness Decline: The STRRIDE Reunion Study. 
  • Short-Term Trajectories of Depressive Symptoms in Stroke Survivors and Their Family Caregivers. 
  • Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. 
  • Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. 
  • Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution. 
  • Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. 
  • Significance of isolated neovascular tufts ("popcorn") in retinopathy of prematurity. 
  • Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis. 
  • Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial. 
  • Singapore Malay Eye Study: rationale and methodology of 6-year follow-up study (SiMES-2). 
  • Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206. 
  • Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens. 
  • Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. 
  • Sinogenic subdural empyema and Streptococcus anginosus. 
  • Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry. 
  • Six-Year Changes in Myopic Macular Degeneration in Adults of the Singapore Epidemiology of Eye Diseases Study. 
  • Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. 
  • Six-year incidence and progression of diabetic retinopathy in Indian adults: the Singapore Indian Eye study. 
  • Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE. 
  • Slowing the progression of chronic renal insufficiency. 
  • Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer. 
  • Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. 
  • Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. 
  • Solitary pulmonary nodules: Part II. Evaluation of the indeterminate nodule. 
  • Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes. 
  • Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis. 
  • Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer. 
  • Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. 
  • Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration. 
  • Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. 
  • Spectrum of immune-mediated inner ear disease and cochlear implant results. 
  • Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010. 
  • Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. 
  • State of the evidence. 
  • Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. 
  • Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. 
  • Statins and age-related macular degeneration: time for a randomized controlled trial? 
  • Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. 
  • Statistical modeling using preoperative prognostic variables in predicting extracapsular extension and progression after radical prostatectomy for prostate cancer. 
  • Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. 
  • Staying ahead of the curve: the use of spinopelvic parameters to predict curve progression and bracing success in adolescent idiopathic scoliosis. 
  • Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. 
  • Stenosing ureteritis in a 7-year-old boy with Henoch-Schönlein purpura nephritis: A case report and review of the literature. 
  • Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy. 
  • Stigma in leprosy: miles to go! 
  • Strategies to enhance the efficacy of intravescical therapy for non-muscle invasive bladder cancer. 
  • Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. 
  • Stromal gene signatures in large-B-cell lymphomas. 
  • Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. 
  • Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial. 
  • Subchondral bone trabecular integrity predicts and changes concurrently with radiographic and magnetic resonance imaging-determined knee osteoarthritis progression. 
  • Subjective cognitive function and decline among older adults with psychometrically defined amnestic MCI. 
  • Summary of the OA biomarkers workshop 2009--biochemical biomarkers: biology, validation, and clinical studies. 
  • Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis. 
  • Suppression of inflammatory disease activity in rheumatoid arthritis is associated with improvements in retinal microvascular health. 
  • Surgery for the Adolescent Idiopathic Scoliosis Patients After Skeletal Maturity: Early Versus Late Surgery. 
  • Surgical management of petroclival meningiomas: defining resection goals based on risk of neurological morbidity and tumor recurrence rates in 137 patients. 
  • Surrogate end points in heart failure trials. 
  • Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage Immunotherapy. 
  • Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials. 
  • Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. 
  • Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis. 
  • Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation. 
  • Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group. 
  • Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry. 
  • Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate. 
  • Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients. 
  • Susac syndrome with transient inverted vision. 
  • Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: correlation with intraocular levels of tumor necrosis factor-alpha and interferon-gamma. 
  • Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. 
  • Symptom Trajectories in Children Receiving Treatment for Leukemia: A Latent Class Growth Analysis With Multitrajectory Modeling. 
  • Symptom challenges after atrial fibrillation ablation. 
  • Symptom management in patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. 
  • Synchronous clear cell renal cell carcinoma and tubulocystic carcinoma: genetic evidence of independent ontogenesis and implications of chromosomal imbalances in tumor progression. 
  • Synergistic Roles of Macrophages and Neutrophils in Osteoarthritis Progression. 
  • Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation. 
  • Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? 
  • Systemic lupus erythematosus. Diagnosis and treatment. 
  • Systems-based approaches to cardiovascular disease. 
  • TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer. 
  • TRIal to slow the Progression Of Diabetes (TRIPOD): study protocol for a randomized controlled trial using wireless technology and incentives. 
  • TSG-6 activity as a novel biomarker of progression in knee osteoarthritis. 
  • Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria. 
  • Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. 
  • Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression. 
  • Targeted interventions to prevent transitioning from acute to chronic low back pain in high-risk patients: development and delivery of a pragmatic training course of psychologically informed physical therapy for the TARGET trial. 
  • Targeted suppression of beta-catenin blocks intestinal adenoma formation in APC Min mice. 
  • Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. 
  • Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm. 
  • Telomerase activity in ductal carcinoma in situ and invasive breast cancer. 
  • Telomerase activity in normal leukocytes and in hematologic malignancies. 
  • Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. 
  • Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity. 
  • Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial. 
  • Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer. 
  • Testosterone in prostate cancer: the Bethesda consensus. 
  • Tetrahydroindenoindole inhibits the progression of diabetes in mice. 
  • Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial. 
  • The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data. 
  • The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. 
  • The CINRG Becker Natural History Study: Baseline characteristics. 
  • The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. 
  • The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP). 
  • The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. 
  • The Duke myasthenia gravis clinic registry: I. Description and demographics. 
  • The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease. 
  • The Emerging Role of Surgery for Patients With Advanced Melanoma Treated With Immunotherapy. 
  • The Evolution of Fibrosis and Atrophy and Their Relationship with Visual Outcomes in Asian Persons with Neovascular Age-Related Macular Degeneration. 
  • The Genomic Landscape of Actinic Keratosis. 
  • The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population. 
  • The National Physicians Cooperative: transforming fertility management in the cancer setting and beyond. 
  • The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials. 
  • The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. 
  • The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. 
  • The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. 
  • The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. 
  • The Relationship Between Asymmetries of Corneal Properties and Rates of Visual Field Progression in Glaucoma Patients. 
  • The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy. 
  • The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society. 
  • The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society. 
  • The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms. 
  • The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. 
  • The SLE-key test serological signature: new insights into the course of lupus. 
  • The STAR*D study: treating depression in the real world. 
  • The STICH trial: evidence-based conclusions. 
  • The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition. 
  • The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds. 
  • The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer. 
  • The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis. 
  • The activity of RhoA is correlated with lymph node metastasis in human colorectal cancer. 
  • The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers--a study of the National Cancer Institute of Canada Clinical Trials Group. 
  • The anterior cruciate ligament and arthritis. 
  • The antibody response in HIV-1 infection. 
  • The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study. 
  • The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer. 
  • The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. 
  • The chronic kidney disease model: a general purpose model of disease progression and treatment. 
  • The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF. 
  • The clinical features of the overlap between COPD and asthma. 
  • The clinical management of HCV in the HIV-infected patient. 
  • The combination of an inflammatory peripheral blood gene expression and imaging biomarkers enhance prediction of radiographic progression in knee osteoarthritis. 
  • The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression. 
  • The continuous heart failure spectrum: moving beyond an ejection fraction classification. 
  • The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options. 
  • The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States. 
  • The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. 
  • The course of depressive symptoms in older adults with comorbid major depression and dysthymia. 
  • The current state of care in gout: Addressing the need for better understanding of an ancient disease. 
  • The development and potential of acoustic radiation force impulse (ARFI) imaging for carotid artery plaque characterization. 
  • The development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model. 
  • The developmental course of illicit substance use from age 12 to 22: links with depressive, anxiety, and behavior disorders at age 18. 
  • The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? 
  • The effect of altered Toll-like receptor 4 signaling on cancer cachexia. 
  • The effect of chronic progressive nephropathy on the incidence of renal tubule cell neoplasms in control male F344 rats. 
  • The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice. 
  • The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance). 
  • The effects of cytotoxic therapy in progressive IgA nephropathy. 
  • The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. 
  • The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. 
  • The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. 
  • The evolution of the histology in pleomorphic xanthoastrocytomas in children: a study of 15 cases. 
  • The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. 
  • The functions and regulation of the PTEN tumour suppressor: new modes and prospects. 
  • The immunological axis in heart failure: importance of the leukocyte differential. 
  • The impact of after-school peer contact on early adolescent externalizing problems is moderated by parental monitoring, perceived neighborhood safety, and prior adjustment. 
  • The impact of menopause on functional status in women with rheumatoid arthritis. 
  • The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. 
  • The importance of stress management among postresection breast cancer patients. 
  • The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA. 
  • The influence of oral statin medications on progression of glaucomatous visual field loss: A propensity score analysis. 
  • The landscape of contemporary clinical trials for untreated metastatic clear cell renal cell carcinoma. 
  • The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness. 
  • The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation. 
  • The mediating role of pain and function in the association between stiffness and quality of life in patients with axial spondyloarthritis. 
  • The microvasculature in chronic kidney disease. 
  • The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. 
  • The natural history of renal function following orthotopic heart transplant. 
  • The need for epidemiologic studies of in-situ carcinoma of the breast. 
  • The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury? 
  • The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. 
  • The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management. 
  • The perplexing complexity of cardiac arrhythmias: beyond electrical remodeling. 
  • The potential role of intrinsic hypoxia markers as prognostic variables in cancer. 
  • The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. 
  • The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. 
  • The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa. 
  • The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. 
  • The progression of fenfluramine-associated valvular heart disease assessed by echocardiography. 
  • The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. 
  • The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C. 
  • The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. 
  • The reciprocal relationships between changes in adolescent perceived prevalence of smoking in movies and progression of smoking status. 
  • The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women. 
  • The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse. 
  • The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
  • The relationship between blood IL-12p40 level and melanoma progression. 
  • The relationship between changes in body mass index and retinal vascular caliber in children. 
  • The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. 
  • The renin-angiotensin system and diabetic nephropathy. 
  • The role of corticosteroids in Duchenne muscular dystrophy: a review for the anesthetist. 
  • The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy. 
  • The role of protein phosphorylation in therapy resistance and disease progression in chronic myelogenous leukemia. 
  • The role of systemic hypertension in the progression of nondiabetic renal disease. 
  • The role of the built environment in the disablement process. 
  • The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases. 
  • The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling. 
  • The type III TGF-beta receptor suppresses breast cancer progression. 
  • The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells. 
  • The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease. 
  • Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies. 
  • Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032. 
  • Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma. 
  • Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer. 
  • Thrombosis and cancer: emerging data for the practicing oncologist. 
  • Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. 
  • Time to antivenom administration is not associated with total antivenom dose administered in a copperhead-predominant snakebite population. 
  • Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. 
  • Time-Dependent Changes in Dural Enhancement Associated With Spontaneous Intracranial Hypotension. 
  • Time-Dependent Effects on Synovial Fluid Composition During the Acute Phase of Human Intra-articular Ankle Fracture. 
  • Time-lapse mapping of cortical changes in schizophrenia with different treatments. 
  • Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. 
  • Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence. 
  • Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. 
  • Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. 
  • Tnni3k modifies disease progression in murine models of cardiomyopathy. 
  • Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer. 
  • Too much of a good thing? Tracing the history of the propofol infusion syndrome. 
  • Topography of geographic atrophy in age-related macular degeneration. 
  • Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study. 
  • Toward an understanding of the correlates of protective immunity to HIV infection. 
  • Toward the development of criteria for global flares in juvenile systemic lupus erythematosus. 
  • Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis. 
  • Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. 
  • Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression. 
  • Trajectories of mobility and IADL function in older patients diagnosed with major depression. 
  • Trajectories of preschool disorders to full DSM depression at school age and early adolescence: continuity of preschool depression. 
  • Trajectory classes of depressive symptoms in a community sample of older adults. 
  • Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression. 
  • Transcriptional network predicts viral set point during acute HIV-1 infection. 
  • Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations. 
  • Transcriptomic analysis of peripheral blood mononuclear cells in rapid progressors in early HIV infection identifies a signature closely correlated with disease progression. 
  • Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. 
  • Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. 
  • Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy. 
  • Transformation of cell type in uveal melanomas: a quantitative histologic analysis. 
  • Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event. 
  • Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model. 
  • Transgenic mice expressing the myotilin T57I mutation unite the pathology associated with LGMD1A and MFM. 
  • Transient and persistent worsening renal function during hospitalization for acute heart failure. 
  • Transition to chronic pain: opportunities for novel therapeutics. 
  • Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. 
  • Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C. 
  • Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. 
  • Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm. 
  • Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study. 
  • Traumatic brain injury and late-life dementia. 
  • Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack. 
  • Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry. 
  • Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke. 
  • Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. 
  • Treatment of patients with pineoblastoma with high dose cyclophosphamide. 
  • Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: Insights from the CAT-HF Trial. 
  • Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. 
  • Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. 
  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. 
  • Trilateral retinoblastoma: clinical and radiologic progression. 
  • Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma. 
  • Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. 
  • Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells. 
  • Tumor progression and transformation of low-grade glial tumors associated with pregnancy. 
  • Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease. 
  • Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy. 
  • Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. 
  • Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. 
  • UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling. 
  • UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression. 
  • ULTRASOUND IN THE DIAGNOSIS AND MONITORING OF AMYOTROPHIC LATERAL SCLEROSIS: A REVIEW. 
  • Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes. 
  • Understanding Articular Cartilage Injury and Potential Treatments. 
  • Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. 
  • Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy. 
  • Unraveling the pathophysiology of acute heart failure: an inflammatory proposal. 
  • Up-regulation of tumor susceptibility gene 101 conveys poor prognosis through suppression of p21 expression in ovarian cancer. 
  • Update in the management of patients with hormone-refractory prostate cancer. 
  • Update on fibroblast growth factor 23 in chronic kidney disease. 
  • Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010. 
  • Updated risk factors should be used to predict development of diabetes. 
  • Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas. 
  • Urgency of emergency department visits by children with sickle cell disease: a comparison of 3 chronic conditions. 
  • Uric Acid and CKD Progression Matures with Lessons for CKD Risk Factor Discovery. 
  • Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression. 
  • Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. 
  • Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. 
  • Urine tricarboxylic acid cycle signatures of early-stage diabetic kidney disease. 
  • Use of atorvastatin in systemic lupus erythematosus in children and adolescents. 
  • Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. 
  • Use of fundus autofluorescence images to predict geographic atrophy progression. 
  • Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a nationwide survey of urologists. 
  • Usefulness of Coronary Artery Calcium to Predict Heart Failure With Preserved Ejection Fraction in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis). 
  • Using genetics to enable studies on the prevention of Alzheimer's disease. 
  • Using imaging for cardiovascular risk prediction: an overview. 
  • Using measures of disease progression to determine therapeutic effect: a sirens' song. 
  • Using the arteriolar Pressure Attenuation Index to predict ocular hypertension progression to open-angle glaucoma. 
  • Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigation. 
  • Utility of LHRH antagonists for advanced prostate cancer. 
  • Utilization of electronic modified early warning score to engage rapid response team early in clinical deterioration. 
  • Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response. 
  • Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT images. 
  • Validation of Rates of Mean Deviation Change as Clinically Relevant End Points for Glaucoma Progression. 
  • Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS). 
  • Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system. 
  • Value of biomarkers in osteoarthritis: current status and perspectives. 
  • Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. 
  • Valvular heart disease. 
  • Variable Genotype-Phenotype Correlation of Pompe's Disease Caused by a c.2015 G > A (p.Arg672Gln) Mutation in the GAA Gene. 
  • Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure. 
  • Variables associated with the progression of hip osteoarthritis: a systematic review. 
  • Variables in predicting survival based on treating "PSA-only" relapse. 
  • Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study. 
  • Variation in early developmental course in autism and its relation with behavioral outcome at 3-4 years of age. 
  • Vascular factors predict rate of progression in Alzheimer disease. 
  • Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. 
  • Vasodilators in aortic regurgitation. 
  • Vegetable Consumption and Progression of Prostate Cancer. 
  • Vein graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells. 
  • Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. 
  • Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. 
  • Ventilation defects on hyperpolarized helium-3 MRI in asthma are predictive of 2-year exacerbation frequency. 
  • Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration. 
  • Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. 
  • Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia. 
  • Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas. 
  • Vitamin D deficiency is not associated with changes in retinal geometric parameters in young people with type 1 diabetes. 
  • Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial. 
  • Vulnerable plaque intervention: State of the art. 
  • WIPI1 is a conserved mediator of right ventricular failure. 
  • Waiting for action on the osteoarthritis front. 
  • Was the role of statins in slowing the progression of abdominal aortic aneurysms underestimated? 
  • Watchful waiting: role of disease progression on uncertainty and depressive symptoms in patients with chronic hepatitis C. 
  • Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience. 
  • Weight-Bearing CT Scan After Tibial Pilon Fracture Demonstrates Significant Early Joint-Space Narrowing. 
  • Well-Child Care Attendance and Risk of Asthma Exacerbations. 
  • What Should We Tell Patients About Physical Activity After a Prostate Cancer Diagnosis? 
  • What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression? 
  • What bothers lung cancer patients the most? A prospective, longitudinal electronic patient-reported outcomes study in advanced non-small cell lung cancer. 
  • What's new in neoadjuvant therapy for breast cancer? 
  • When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysis. 
  • Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? 
  • White matter hyperintensity progression and late-life depression outcomes. 
  • White matter in different regions evolves differently during progression to dementia. 
  • Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia. 
  • Will submandibular TCD prevent stroke in children with sickle cell anemia? 
  • Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4. 
  • Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale. 
  • Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies. 
  • Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week. 
  • Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. 
  • Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF). 
  • Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. 
  • Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme. 
  • Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study. 
  • Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. 
  • [A severe course of bullous pemphigoid in a young man]. 
  • p38 MAPK in development and cancer. 
  • p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy. 
  • xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression. 
  • β-Arrestin2 mediates progression of murine primary myelofibrosis. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Charles, Hal Cecil, Adjunct Associate Professor in the Department of Radiology, Radiology
  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology
  • Dodge, Kenneth A., William McDougall Distinguished Professor of Public Policy Studies, Duke Science & Society
  • Farsiu, Sina, Professor in the Department of Biomedical Engineering, Electrical and Computer Engineering
  • Halabi, Susan, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Hogan, Brigid L. M., Research Professor of Cell Biology, Cell Biology
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Mruthyunjaya, Prithvi, Adjunct Associate Professor in the Department of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Olsen, Maren Karine, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Pang, Herbert, Adjunct Assistant Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Roy Choudhury, Kingshuk, Adjunct Associate Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Schanberg, Laura Eve, Professor of Pediatrics, Pediatrics, Rheumatology
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Toth, Cynthia Ann, Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology, Biomedical Engineering
  • Tsalik, Ephraim, Adjunct Associate Professor in the Department of Medicine, Medicine, Infectious Diseases
  • Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology